<?xml version="1.0" ?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.3 20210610//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">elife</journal-id>
<journal-id journal-id-type="publisher-id">eLife</journal-id>
<journal-title-group>
<journal-title>eLife</journal-title>
</journal-title-group>
<issn publication-format="electronic" pub-type="epub">2050-084X</issn>
<publisher>
<publisher-name>eLife Sciences Publications, Ltd</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">92731</article-id>
<article-id pub-id-type="doi">10.7554/eLife.92731</article-id>
<article-id pub-id-type="doi" specific-use="version">10.7554/eLife.92731.1</article-id>
<article-version-alternatives>
<article-version article-version-type="publication-state">reviewed preprint</article-version>
<article-version article-version-type="preprint-version">1.1</article-version>
</article-version-alternatives>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Medicine</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Depletion of SMN Protein in Mesenchymal Progenitors Impairs the Development of Bone and Neuromuscular Junction in Spinal Muscular Atrophy</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0871-3414</contrib-id>
<name>
<surname>Hann</surname>
<given-names>Sang-Hyeon</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="author-notes" rid="n1">*</xref></contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Kim</surname>
<given-names>Seon-Yong</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="author-notes" rid="n1">*</xref></contrib>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Ye-Lynne</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jo</surname>
<given-names>Young-Woo</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kang</surname>
<given-names>Jong-Seol</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Park</surname>
<given-names>Hyerim</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Choi</surname>
<given-names>Se-Young</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="corresp" rid="cor1">#</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Kong</surname>
<given-names>Young-Yun</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="corresp" rid="cor1">#</xref>
</contrib>
<aff id="a1"><label>1</label><institution>School of Biological Sciences, Seoul National University</institution>, Seoul 08826, <country>Republic of Korea</country></aff>
<aff id="a2"><label>2</label><institution>Department of Physiology, Dental Research Institute, Seoul National University School of Dentistry</institution>, Seoul, 03080, <country>Republic of Korea</country></aff>
</contrib-group>
<contrib-group content-type="section">
<contrib contrib-type="editor">
<name>
<surname>Ryu</surname>
<given-names>Vitaly</given-names>
</name>
<role>Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>Icahn School of Medicine at Mount Sinai</institution>
</institution-wrap>
<city>New York</city>
<country>United States of America</country>
</aff>
</contrib>
<contrib contrib-type="senior_editor">
<name>
<surname>Behrens</surname>
<given-names>Timothy E</given-names>
</name>
<role>Senior Editor</role>
<aff>
<institution-wrap>
<institution>University of Oxford</institution>
</institution-wrap>
<city>Oxford</city>
<country>United Kingdom</country>
</aff>
</contrib>
</contrib-group>
<author-notes>
<fn fn-type="equal" id="n1"><label>*</label><p>These authors contributed equally to this work</p></fn>
<corresp id="cor1"><label>#</label>Correspondence and requests for materials should be addressed to Y.Y.K. (<email>ykong@snu.ac.kr</email>) and S.Y.C. (<email>sychoi@snu.ac.kr</email>)</corresp>
</author-notes>
<pub-date date-type="original-publication" iso-8601-date="2023-11-07">
<day>07</day>
<month>11</month>
<year>2023</year>
</pub-date>
<volume>12</volume>
<elocation-id>RP92731</elocation-id>
<history>
<date date-type="sent-for-review" iso-8601-date="2023-09-21">
<day>21</day>
<month>09</month>
<year>2023</year>
</date>
</history>
<pub-history>
<event>
<event-desc>Preprint posted</event-desc>
<date date-type="preprint" iso-8601-date="2023-10-10">
<day>10</day>
<month>10</month>
<year>2023</year>
</date>
<self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2023.10.06.561282"/>
</event>
</pub-history>
<permissions>
<copyright-statement>Â© 2023, Hann et al</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Hann et al</copyright-holder>
<ali:free_to_read/>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="elife-preprint-92731-v1.pdf"/>
<abstract>
<title>Abstract</title>
<p>Spinal Muscular Atrophy (SMA) is a neuromuscular disorder characterized by the deficiency of the survival motor neuron (SMN) protein, which leads to motor neuron dysfunction and muscle atrophy. In addition to the requirement for SMN in motor neurons, recent studies suggest that SMN deficiency in peripheral tissues plays a key role in the pathogenesis of SMA. Using limb mesenchymal progenitor cells (MPCs)-specific SMN-depleted mouse models, we reveal that SMN reduction in chondrocytes and fibro-adipogenic progenitors (FAPs) derived from limb MPCs causes defects in the development of bone and neuromuscular junction (NMJ), respectively. We show that impaired growth plate homeostasis, which causes skeletal growth defects in SMA, is cell-autonomous due to SMN ablation in chondrocytes. Furthermore, the reduction of SMN in FAPs resulted in abnormal NMJ maturation, altered release of neurotransmitters, and NMJ morphological defects. Transplantation of healthy FAPs rescued the morphological deterioration. Our findings highlight the significance of mesenchymal SMN in neuromusculoskeletal pathogenesis in SMA and provide insights into potential therapeutic strategies targeting mesenchymal cells for the treatment of SMA.</p>
</abstract>

</article-meta>
<notes>
<notes notes-type="competing-interest-statement">
<title>Competing Interest Statement</title><p>The authors have declared no competing interest.</p></notes>
</notes>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>The survival motor neuron (SMN) protein is a crucial component of the spliceosome complex and is essential for the proper function of all cell types (Mercuri et al., 2022). Deficiency in SMN protein disrupts the formation of spliceosome complexes, ultimately causing splicing defects in multiple genes. Mutations in the SMN1 gene, which encodes the SMN protein, give rise to the neuromuscular disorder Spinal Muscular Atrophy (SMA). SMA is characterized by neuromuscular junctions (NMJ) disruption, muscular atrophy, and alpha motor neuron loss (Mercuri et al., 2022; Burghes et al., 2009). The severity of the disease in humans correlates with the copy number of SMN2, which is a paralog of SMN1 in humans. SMN2 primarily produces less functional exon 7-deleted SMN protein and rarely generates a limited quantity of functional full-length SMN protein via alternative splicing. SMA patients are classified into types 0 through 4 based on the severity and timing of disease onset, predominantly determined by the number of copies of the SMN2 gene they possess. More than 50% of SMA patients are categorized as type 1, characterized by muscle defects with proximal muscle atrophy during infancy, eventually resulting in death within a few years (Mercuri et al., 2022).</p>
<p>Previous studies suggest that the onset of SMA is mainly attributed to SMN loss in motor neurons (<xref ref-type="bibr" rid="c39">Monani et al., 2000</xref>; Burghes et al., 2009). Nevertheless, motor neuron-specific SMN deficiency in the SMA mouse model exhibits relatively mild phenotypes compared to whole-body SMA mouse models (Park et al., 2010; <xref ref-type="bibr" rid="c35">McGovern et al., 2015</xref>). Furthermore, restoring SMN to motor neurons in SMA mouse models result in only partial rescue in lifespan and neuromuscular defects (<xref ref-type="bibr" rid="c21">Passini et al., 2010</xref>; <xref ref-type="bibr" rid="c33">Martinez et al., 2012</xref>; <xref ref-type="bibr" rid="c35">McGovern et al., 2015</xref>; <xref ref-type="bibr" rid="c3">Besse et al., 2020</xref>). Systemic administration of antisense oligonucleotide (ASO), which corrects SMN2 splicing to restore SMN expression, significantly prolongs survival compared to CNS administration (<xref ref-type="bibr" rid="c20">Hua et al., 2011</xref>). In the mouse treated with a systemically delivered ASO, blocking the effect of ASO in the CNS by a complementary decoy did not have any detrimental effect on survival, motor function, or NMJ integrity (Hua et al., 2015). These studies suggest that peripheral SMN plays a crucial part in SMA pathology. Overall, investigating the impacts of SMN depletion in peripheral tissues is critical for alleviating neuromuscular impairments and increasing life expectancy in SMA.</p>
<p>In SMA patients, bone growth retardation has been observed (<xref ref-type="bibr" rid="c27">Khatri et al., 2008</xref>; <xref ref-type="bibr" rid="c54">Vai et al., 2015</xref>; <xref ref-type="bibr" rid="c57">Wasserman et al., 2017</xref>; <xref ref-type="bibr" rid="c2">Baranello et al., 2019</xref>; <xref ref-type="bibr" rid="c18">Hensel et al., 2020</xref>). Studies using whole-body SMA mouse models have revealed that this is caused by diminished growth plate chondrocyte proliferation and extracellular matrix (ECM) remodeling defects, independent of muscle atrophy (<xref ref-type="bibr" rid="c18">Hensel et al., 2020</xref>). However, it is still unclear whether these defects result from an internal factor such as SMN ablation in chondrocytes, or an external factor such as IGF1 decline in SMA patients and mice (<xref ref-type="bibr" rid="c20">Hua et al., 2011</xref>; Yesbek-Kaymaz et al., 2016).</p>
<p>Mesenchymal progenitor cells (MPCs) derived from the lateral plate mesoderm (LPM) differentiate into various types of limb mesenchymal cells, including bone, cartilage, and intramuscular mesenchymal cells like fibro-adipogenic progenitors (FAPs) (<xref ref-type="bibr" rid="c40">Nassari et al., 2017</xref>). Recent studies have revealed the role of FAPs in skeletal muscle homeostasis, as reducing the number of FAPs resulted in diminished muscle regeneration capacity, long-term muscle atrophy, and NMJ denervation (<xref ref-type="bibr" rid="c59">Wosczyna et al., 2019</xref>; <xref ref-type="bibr" rid="c53">Uezumi et al., 2021</xref>). Our latest research demonstrated that FAPs-specific deficiency of Bap1, one of the deubiquitinases, leads to NMJ defects (<xref ref-type="bibr" rid="c29">Kim et al., 2022</xref>). These recent findings raise the possibility that FAPs may have a specific role in the pathogenesis of neuromuscular diseases such as SMA. However, it has not been studied if depletion of SMN in FAPs can lead to SMA-like neuromuscular pathology.</p>
<p>In this study, we crossed a limb MPCs-specific Cre mouse with a floxed Smn exon7 mouse carrying multiple copies of the human SMN2 gene, allowing us to examine the impact of mesenchymal SMN reduction on SMA pathogenesis. Our findings indicate that the SMN reduction in FAPs, similar to the extent of severe SMA, causes altered NMJ development like SMA. Additionally, in chondrocytes, it leads to skeletal growth abnormalities due to growth plate cell-autonomous defects.</p>
</sec>
<sec id="s2">
<title>Results</title>
<sec id="s2a">
<title>Bone growth restriction due to growth plate cell-autonomous defects caused by MPCs-specific SMN depletion</title>
<p>To investigate the effects of SMN reduction within MPCs in SMA pathogenesis, we crossed <italic>Smn<sup>f7/f7</sup></italic> mice, which possess loxP sites flanking exon 7 of the Smn gene (<xref ref-type="bibr" rid="c16">Frugier et al., 2000</xref>), with <italic>Prrx1<sup>Cre</sup></italic> mice. This produced Smn<sup>ÎMPC</sup> mice (<italic>Prrx1<sup>Cre</sup>; Smn<sup>f7/f7</sup></italic>) that lacked the Smn gene specifically in Prrx1<sup>Cre</sup>-expressed limb MPCs that give rise to bone, cartilage, and FAPs (Logan et al., 2002; <xref ref-type="bibr" rid="c31">Leinroth et al., 2022</xref>). To ascertain whether mutant mice carrying the SMN2 gene, like SMA patients, present pathological phenotypes, we additionally generated SMN2 2-copy Smn<sup>ÎMPC</sup> (<italic>Prrx1<sup>Cre</sup>; Smn<sup>f7/f7</sup>; SMN2<sup>+/+</sup>)</italic> and SMN2 1-copy Smn<sup>ÎMPC</sup> (<italic>Prrx1<sup>Cre</sup>; Smn<sup>f7/f7</sup>; SMN2<sup>+/0</sup></italic>) mice. Control littermates that lacked Prrx1<sup>Cre</sup> were used as controls for comparison.</p>
<p>SMN2 0-copy Smn<sup>ÎMPC</sup> mice died within 24 hours after birth. Regions where limbs should have formed at E18.5 only had rudimentary limb structures (<xref rid="figs1_1" ref-type="fig">Figure 1âfigure supplement 1A</xref>). Furthermore, since the upper head bone did not envelop the brain, it was directly attached to the skin and protruded. These observations can be attributed to Prrx1<sup>Cre</sup>-mediated SMN deletion in the LPM-derived limb MPCs and the craniofacial mesenchyme, which is accountable for the formation of calvarial bone (<xref ref-type="bibr" rid="c58">Wilk et al., 2017</xref>). To investigate whether the lack of SMN proteins in MPCs is responsible for bone development abnormalities, we performed alcian blue and alizarin red staining on E18.5 SMN2 0-copy Smn<sup>ÎMPC</sup> mutants to analyze the structure of bones and cartilage. The appendages displayed restricted bone and cartilage formations, with scarcely discernible femur and tibia (<xref rid="figs1_1" ref-type="fig">Figure 1âfigure supplement 1B-C</xref>). In the cranial region, there was an absence of both cartilage and bone at the location of the calvarial bone, with the parietal bone entirely missing and partially absent frontal bone (<xref rid="figs1_1" ref-type="fig">Figure 1âfigure supplement 1D</xref>). Additionally, the sternum, which is one of the bones originating from the LPM (Sheng et al., 2015), was shorter than the control (<xref rid="figs1_1" ref-type="fig">Figure 1âfigure supplement 1E</xref>).</p>
<p>The SMN2 2-copy Smn<sup>ÎMPC</sup> mice, carrying two homologous SMN2 genes, did not show any discernible differences from the Prrx1<sup>Cre</sup>-negative control littermates into adulthood. However, the SMN2 1-copy Smn<sup>ÎMPC</sup> mice exhibited reduced body size and shorter limb length compared to the SMN2 1-copy control (Smn<sup>f7/f7</sup>; SMN2<sup>+/0</sup>). To assess postnatal bone growth defects observed in SMA patients and mouse models, we conducted micro-CT analysis on femurs obtained from postnatal day 14 (P14) SMN2 1-copy Smn<sup>ÎMPC</sup> and SMN2 2-copy Smn<sup>ÎMPC</sup> mice (<xref rid="fig1" ref-type="fig">Figure 1A</xref>). The data showed that SMN2 1-copy mutants exhibited reduced femur diaphysis length, diameter, and trabecular bone volume compared to the control group, indicating bone formation defects (<xref rid="fig1" ref-type="fig">Figure 1B-D</xref>). We then examined femoral bone thickness and diaphyseal bone mineral density (BMD) to determine whether mineralization was normal after bone formation. The thickness of the bone in the mutants did not differ significantly from the control, suggesting that bone mineralization was intact (<xref rid="figs1_1" ref-type="fig">Figure 1âfigure supplement 1E-F</xref>). Unexpectedly, BMD slightly increased in SMN2 1-copy mutants compared to the control group (<xref rid="figs1_1" ref-type="fig">Figure 1âfigure supplement 1G</xref>). The higher BMD may be attributed to greater mechanical stress caused by the shorter femur supporting the weight of the body, consistent with prior research indicating that elevated mechanical force leads to higher BMD in the femur (<xref ref-type="bibr" rid="c19">Hoxha et al., 2014</xref>; <xref ref-type="bibr" rid="c23">Ike et al., 2015</xref>). Nevertheless, the decrease in bone growth without apparent deterioration in bone mineralization of the femur of SMN2 1-copy Smn<sup>ÎMPC</sup> mutants is consistent with findings from the whole-body SMA mouse model (<xref ref-type="bibr" rid="c18">Hensel et al., 2020</xref>). Collectively, these results suggest that mice carrying low copies of SMN2, with the SMN gene specifically deleted in MPCs, exhibit bone growth defects.</p>
<fig id="fig1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 1</label>
<caption><p>Skeletal growth abnormalities by limb mesenchymal cell-specific SMN depletion in SMN2 1-copy Smn<sup>ÎMPC</sup> mice. (<bold>A</bold>) Representative 3D images of ossified femur bone. Scale bars, 1 mm. (<bold>B-C</bold>) SMN2 1-copy mutantâs femurs showed reduced growth in diaphysis length and diameter, and (<bold>D</bold>) decreased trabecular bone volume. (<bold>E-F</bold>) Trabecular and cortical bone thicknesses were not significantly different between the control and mutant groups. (<bold>G</bold>) Bone mineral density was slightly increased in the diaphysis of SMN2 1-copy Smn<sup>ÎMPC</sup> mice. The micro CT analysis was performed in femur diaphysis and metaphysis from SMN2 1-copy Smn<sup>ÎWT</sup>, SMN2 2-copy, and 1-copy Smn<sup>ÎMPC</sup> mice at P14. 1-way ANOVA with Tukeyâs post hoc test, n = 3-5 mice in each genotype (<bold>B-G</bold>). (<bold>H</bold>) Representative images of genomic PCR analysis from SMN2 1-copy Smn<sup>ÎMPC</sup> mice tissues at P21. (<bold>I</bold>) qRT PCR analysis from tissues of SMN2 1-copy Smn<sup>WT</sup> and Smn<sup>ÎMPC</sup> mice at P21 (n = 3 mice in each genotype; Unpaired t-test with Welchâs correction). Deletion of Smn exon 7 was detected only in limb mesenchymal cells using genomic PCR (<bold>H</bold>) and mRNA expression (<bold>I</bold>). (<bold>J</bold>) Representative images of western blot analysis in cultured FAPs. SMN protein in FAPs of SMN2 1-copy Smn<sup>ÎMPC</sup> mice exhibited a decrease comparable to that observed in the SMAÎ7 mice. (<bold>K</bold>) Relative SMN levels in cultured FAPs of the controls and mutants (n = 3 mice in each genotype; 1-way ANOVA with Tukeyâs post hoc test). ns; not significantly different. *<italic>p</italic> &lt; 0.05; **<italic>p</italic> &lt; 0.01; ***<italic>p</italic> &lt; 0.001; ****<italic>p</italic> &lt; 0.0001. Error bars show s.e.m.</p></caption>
<graphic xlink:href="561282v1_fig1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>To determine whether bone growth defects in SMN2 1-copy Smn<sup>ÎMPC</sup> mutants arise from disrupted chondrocyte homeostasis at growth plates, we stained the femur growth plate of P14 mice with hematoxylin and eosin (<xref rid="figs1_2" ref-type="fig">Figure 1âfigure supplement 2A</xref>). In line with earlier findings in whole-body SMA mice (<xref ref-type="bibr" rid="c18">Hensel et al., 2020</xref>), SMN2 1-copy Smn<sup>ÎMPC</sup> mice exhibited shorter proliferative and hypertrophic zones compared to control mice (<xref rid="figs1_2" ref-type="fig">Figure 1âfigure supplement 2B-D</xref>). Additionally, there was a significant reduction in the number of chondrocytes in the hypertrophic zone (<xref rid="figs1_1" ref-type="fig">Figure 1âfigure supplement 1J</xref>). Our data indicate that adequate expression of SMN is essential for the homeostasis of chondrocytes at growth plates.</p>
</sec>
<sec id="s2b">
<title>Mesenchymal cell-specific SMN reduction similar to severe SMA mouse model in SMN2 1-copy Smn<sup>ÎMPC</sup> mutants</title>
<p>The proliferation and differentiation of growth plate chondrocytes are regulated by extrinsic factors such as GH-IGF-I, glucocorticoids, and estrogen (Shim et al., 2015; Karimian et al., 2012; Shantanam et al., 2018). Previous research indicates that reduced expression of Igf-I/Igfbp3/Igfals in the liver leads to impaired chondrocyte proliferation and shorter femur length, emphasizing the importance of these factors in postnatal bone development (<xref ref-type="bibr" rid="c60">Yakar et al., 2002</xref>; <xref ref-type="bibr" rid="c61">Yakar et al., 2009</xref>). As the IGF pathway proteins are downregulated in whole-body SMA mice, the bone growth defects observed in the mice have sparked debate as it remains unclear whether they are due to intrinsic factors, such as chondrocyte SMN reduction, or the low IGF axis level (<xref ref-type="bibr" rid="c20">Hua et al., 2011</xref>; <xref ref-type="bibr" rid="c52">Tsai et al., 2014</xref>; <xref ref-type="bibr" rid="c12">Deguise et al., 2021</xref>; Hensel et al., 2015).</p>
<p>To clarify this issue, we used Smn<sup>ÎMPC</sup> mutant mice, which enabled us to investigate the effect of SMN depletion in chondrocytes on bone growth, while circumventing the impact of external factors. To confirm the specific deletion of Smn in limb mesenchymal cells, including chondrocytes and FAPs, we performed qRT-PCR for full-length Smn mRNA expression in each tissue. Our findings indicate that full-length Smn mRNA expression in the brain, liver, skeletal muscle, and spinal cord of SMN2 1-copy Smn<sup>ÎMPC</sup> mice at postnatal day 21 (P21) was similar to that of control mice, while it was significantly reduced in isolated FAPs and chondrocytes (<xref rid="fig1" ref-type="fig">Figure 1I</xref>). Additionally, we confirmed the presence of the SmnÎ7 variant, which is the exon 7-deleted form of Smn created by cre-lox mediated recombination, in both FAPs and chondrocytes by conducting genomic PCR on the SMN2 1-copy Smn<sup>ÎMPC</sup> mutant (<xref rid="fig1" ref-type="fig">Figure 1H</xref>). Since SMN was not down-regulated in the tissues other than limb mesenchymal cells, non-mesenchymal cells were ruled out from being responsible for the phenotype observed in Smn<sup>ÎMPC</sup> mutants. Indeed, the liverâs mRNA expression of IGF pathway genes, reported to be decreased in SMA mouse models and patients (<xref ref-type="bibr" rid="c20">Hua et al., 2011</xref>; Deguise., 2021; <xref ref-type="bibr" rid="c47">Sahashi et al., 2013</xref>), showed no difference when comparing controls to SMN2 1-copy Smn<sup>ÎMPC</sup> mutants (<xref rid="figs1_2" ref-type="fig">Figure 1âfigure supplement 2E</xref>). Based on these findings, we concluded that the bone growth defects observed in the whole-body SMA mouse model are mainly due to a depletion of SMN in chondrocytes.</p>
<p>Among our Smn<sup>ÎMPC</sup> models, mice with two copies of SMN2 exhibit similar bone development parameters as control mice without SMN deletion. However, mice with one copy of SMN2 display bone pathological defects akin to SMA mouse models. This may be because the quantity of human full-length SMN protein produced by SMN2 2-copy, was sufficient to sustain SMN complex function in the SMN2 2-copy Smn<sup>ÎMPC</sup> mutants, despite the absence of functional mouse SMN protein in limb mesenchymal cells. On the contrary, due to the lower expression of full-length SMN compared to SMN2 2-copy mutants, the SMN complex may not function properly in SMN2 1-copy mutant cells. We confirmed this by comparing the amount of full-length SMN protein in isolated FAPs from the hindlimbs of control, Smn<sup>ÎMPC</sup> mutants, and a severe SMA mouse model (<italic>Smn<sup>-/-</sup>; SMN2<sup>+/+</sup>; SMNÎ7<sup>+/+</sup></italic>; - SMAÎ7 mutants -) (<xref rid="fig1" ref-type="fig">Figure 1I</xref>). The data show that SMN2 1-copy Smn<sup>ÎMPC</sup> mutants exhibited â¼80% reduction in SMN levels compared to the control group. The level of SMN protein in SMN2 1-copy Smn<sup>ÎMPC</sup> mutants was similar to that in SMAÎ7 mutants. Conversely, SMN2 2-copy mutants display a decrease of approximately 40% in SMN protein levels compared to the control (<xref rid="fig1" ref-type="fig">Figure 1J</xref>). The moderately reduced expression of SMN is adequate to support regular bone development in SMN2 2-copy mutants. Taken together, our findings indicate that the reduction of mesenchymal SMN to levels comparable to that of the severe SMA mouse model causes SMA-like bone pathology in the SMN2 1-copy mutant.</p>
</sec>
<sec id="s2c">
<title>Abnormal NMJ maturation in SMN2 1-copy Smn<sup>ÎMPC</sup> mutants</title>
<p>To investigate whether disabling SMN in FAPs results in SMA-like neuromuscular impairments, we assessed if NMJ phenotypes observed in SMA mouse models also occur in SMN2 1-copy Smn<sup>ÎMPC</sup> mutants. Both severe and mild SMA mouse models exhibit impaired NMJ maturation markers, including plaque-like morphology of acetylcholine receptor (AChR) clusters, neurofilament (NF) varicosities, and poor terminal arborization (<xref ref-type="bibr" rid="c30">Kong et al., 2009</xref>; Martinez, 2012; <xref ref-type="bibr" rid="c38">Monani et al., 2003</xref>; <xref ref-type="bibr" rid="c25">Kariya et al., 2008</xref>). To evaluate the impact of SMN deficiency in FAPs on NMJ maturation, we evaluated the NMJ maturation markers in the TA muscles of control and SMN2 1-copy Smn<sup>ÎMPC</sup> mutant mice at P21, a time when NMJ maturation is in progress (<xref rid="fig2" ref-type="fig">Figure 2A</xref>). Our examination revealed the presence of NF varicosities in SMN2 1-copy mutants as compared with control mice (<xref rid="fig2" ref-type="fig">Figure 2A</xref> and <xref rid="fig2" ref-type="fig">2D</xref>). Additionally, the number of nerve branches was decreased and half of the total NMJs were poorly arborized in SMN2 1-copy mutants (<xref rid="fig2" ref-type="fig">Figure 2B-C</xref>). These presynaptic alterations are specific phenotypes in neurogenic atrophy like SMA. Unlike neurogenic atrophy, physiologic atrophy shows no differences in presynaptic morphology, such as nerve branching (<xref ref-type="bibr" rid="c13">Deschenes et al., 2006</xref>). This suggests that the NMJ phenotypes observed in SMN2 1-copy Smn<sup>ÎMPC</sup> mutant mice are not caused by decreased muscle size and activity resulting from bone growth abnormalities. The morphology of AChR clusters shows that the mutants have more immature plaque-like NMJs than the controlsâ pretzel-like structure (<xref rid="fig2" ref-type="fig">Figure 2E</xref>). Therefore, these findings indicate that SMN2 1-copy Smn<sup>ÎMPC</sup> mutants exhibit NMJ maturation abnormalities common in SMA mouse models.</p>
<fig id="fig2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 2</label>
<caption><p>Aberrant postnatal NMJ maturation in SMN2 1-copy Smn<sup>ÎMPC</sup> mice. (<bold>A</bold>) Immunostaining of NMJs in TA muscle of SMN2 1-copy Smn<sup>WT</sup> and Smn<sup>ÎMPC</sup> mice at P21 with anti-NF (Green), anti-synaptophysin (Blue), Î±-Btx staining AChR (Red). Scale bars, 20 Î¼m. The confocal images of NMJs showed decreased presynaptic terminal branching and the existence of nerve terminal varicosities that were enlarged with NF (indicated by arrowheads) in the mutant. (<bold>B</bold>) The NMJs of the SMN2 1-copy mutant exhibited a significant decrease in presynaptic terminal arborization and (<bold>C</bold>) an increased percentage of poorly arborized NMJs (n = 3 mice in each genotype; Unpaired t-test with Welchâs correction). (<bold>D</bold>) The percentage of NMJs exhibiting NF varicosities was higher in the SMN2 1-copy mutant group than in the control group (n = 3-4 mice in each genotype; Unpaired t-test with Welchâs correction). (<bold>E</bold>) For quantification of the NMJ maturation stage, we classified NMJs into five distinct developmental stages (Plaque: Plaque-shaped endplate without any perforation; Small perforated: Plaque-shaped endplate with small perforations; Large perforated: Plaque-shaped endplate with large perforations; Open: C-shaped endplate; Branched: Pretzel-like branched-shaped endplate) and then compared the frequency patterns of SMN2 1-copy control and mutant mice (n = 3 mice in each genotype; 2-way ANOVA with Tukeyâs post hoc test). The NMJs of SMN2 1-copy mutants displayed plaque-like shapes, indicating that they were in the immature stage. (<bold>F</bold>) Immunostaining of NMJs in TA muscle of SMN2 1-copy Smn<sup>WT</sup> and Smn<sup>ÎMPC</sup> mice at P3 with anti-NF (Green), anti-synaptophysin (Blue), Î±-Btx staining AChR (Red). Scale bars, 10 Î¼m. (<bold>G</bold>) There were no significant differences in AChR cluster size between the SMN2 1-copy control and mutant at P3 (n = 3-4 mice in each genotype; Unpaired t-test with Welchâs correction). (<bold>H</bold>) The ratio of the Synaptophysin area to the AChR area in NMJ was slightly higher in the SMN2 1-copy mutant at P3 (n = 3-4 mice in each genotype; Unpaired t-test with Welchâs correction). ns; not significantly different. *<italic>p</italic> &lt; 0.05; **<italic>p</italic> &lt; 0.01; ***<italic>p</italic> &lt; 0.001; ****<italic>p</italic> &lt; 0.0001. All box-and-whisker plots show the median, interquartile range, minimum, and maximum. For the bar and line graph, error bars show s.e.m.</p></caption>
<graphic xlink:href="561282v1_fig2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s2d">
<title>Undisturbed NMJ formation in neonatal SMN2 1-copy Smn<sup>ÎMPC</sup> mutants</title>
<p>To determine whether any NMJ defects were present prior to juvenile NMJ maturation in SMN2 1-copy Smn<sup>ÎMPC</sup>, we examined NMJ formation in SMN2 1-copy Smn<sup>ÎMPC</sup> mice at the neonatal stage on postnatal day 3. We evaluated the AChR and nerve terminal areas to assess postsynaptic and presynaptic development, respectively (<xref rid="fig2" ref-type="fig">Figure 2F</xref>). Measurements of AChR cluster size indicated no differences between control and SMN2 1-copy Smn<sup>ÎMPC</sup> mice (<xref rid="fig2" ref-type="fig">Figure 2G</xref>). However, the area of AChR covered by nerve terminals was slightly larger in SMN2 1-copy Smn<sup>ÎMPC</sup> (<xref rid="fig2" ref-type="fig">Figure 2H</xref>). We have no reasonable explanation for why the coverage is higher in the mutant. However, there does not appear to be abnormal development of the NMJ in the mutant, at least until the neonatal period. Therefore, we reasoned that SMN2 1-copy Smn<sup>ÎMPC</sup> mutants began to exhibit deterioration in the NMJ maturation during the juvenile stage, following the intact neonatal development of NMJ.</p>
</sec>
<sec id="s2e">
<title>Aberrant NMJ morphology in the adult SMN2 1-copy Smn<sup>ÎMPC</sup> mice</title>
<p>To evaluate the organization of NMJ after the conclusion of postnatal NMJ development, considering mesenchymal SMN expression, we examined NMJ morphology in the TA muscle of control, SMN2 1-copy, and 2-copy Smn<sup>ÎMPC</sup> mice at postnatal day 56 (P56). Our analysis revealed that presynapses were fragmented in SMN2 1-copy mutants, resulting in a bouton-like morphology, in contrast to the control and SMN2 2-copy Smn<sup>ÎMPC</sup> mice (<xref rid="fig3" ref-type="fig">Figure 3A</xref>). In SMN2 1-copy Smn<sup>ÎMPC</sup> mice, a two-fold presynaptic fragmentation compared to the control was quantified, demonstrating nerve terminal shrinkage (<xref rid="fig3" ref-type="fig">Figure 3B</xref>). Additionally, NF ends displayed more severe varicosities than at P21 and were only connected to the proximal nerve by very thin NF, unlike control and SMN2 2-copy mice (<xref rid="fig3" ref-type="fig">Figure 3C</xref>). Remarkably, numerous presynaptic islands formed in SMN2 1-copy Smn<sup>ÎMPC</sup> mice through the merging of fragmented presynapses and NF varicosity. In SMN2 1-copy mutants, AChR clusters displayed fragmented grape-shaped morphology that overlapped with nerve terminals, whereas control and SMN2 2-copy mice displayed pretzel-like structures (<xref rid="fig3" ref-type="fig">Figure 3D</xref>). These results suggest that defects in adult NMJ morphology occur when mesenchymal SMN protein is reduced to the extent of the SMN2 1-copy Smn<sup>ÎMPC</sup> mutants.</p>
<fig id="fig3" position="float" orientation="portrait" fig-type="figure">
<label>Figure 3</label>
<caption><p>Morphological deterioration in NMJs of adult SMN2 1-copy Smn<sup>ÎMPC</sup> mice. (<bold>A</bold>) Immunostaining of NMJs in TA muscle of SMN2 1-copy Smn<sup>WT</sup>, SMN 2-copy, and SMN2 1-copy Smn<sup>ÎMPC</sup> mice at P56 with anti-NF (Green), anti-synaptophysin (Blue), Î±-Btx staining AChR (Red). Scale bars, 20 Î¼m. The confocal images of NMJs showed fragmentation and bouton-like NF varicosities (indicated by arrowheads) in the SMN2 1-copy Smn<sup>ÎMPC</sup> mice. (<bold>B</bold>-<bold>D</bold>) The NMJs of the SMN2 1-copy mutant displayed fragmented presynapse (<bold>B</bold>), endplate (<bold>D</bold>), and NF varicosities (<bold>C</bold>) compared to SMN2 1-copy Smn<sup>WT</sup> and SMN2 2-copy Smn<sup>ÎMPC</sup> mice (n = 3-5 mice in each genotype; Presynaptic fragments &amp; AChR fragments: BrownâForsythe and Welch ANOVA with Games-Howellâs test; NF varicosities: 1-way ANOVA with Tukeyâs post hoc test). ns; not significantly different. ****<italic>p</italic> &lt; 0.0001. All box-and-whisker plots show the median, interquartile range, minimum, and maximum. For the bar graph, error bars show s.e.m.</p></caption>
<graphic xlink:href="561282v1_fig3.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s2f">
<title>Presynaptic neurotransmission alteration in SMN2 1-copy Smn<sup>ÎMPC</sup> mutants</title>
<p>To investigate whether the morphologically aberrant NMJs of SMN2 1-copy Smn<sup>ÎMPC</sup> mice have functional impairments, we isolated hindlimb extensor digitorum longus (EDL) muscles from P56 mice and conducted electrophysiological recording. We incubated the muscles with Î¼-conotoxin, which selectively inhibits muscle voltage-gated Na+ channels, prevented the induction of muscle action potential (<xref ref-type="bibr" rid="c32">Ling et al., 2010</xref>; Zanetti 2018), and recorded the Miniature endplate potential (mEPP) and evoked endplate potential (eEPP). (<xref ref-type="bibr" rid="c32">Ling et al., 2010</xref>; Zanetti 2018). mEPP, a response that occurs when spontaneously released acetylcholine binds to nicotinic AChR without nerve stimulation, was measured ex vivo near the NMJs of the EDL muscles in the control and SMN2 1-copy Smn<sup>ÎMPC</sup> mice (<xref rid="fig4" ref-type="fig">Figure 4A</xref>). The mEPP amplitude was increased in SMN2 1-copy Smn<sup>ÎMPC</sup> mice (<xref rid="fig4" ref-type="fig">Figure 4B</xref>), whereas mEPP frequency was comparable between the controls and mutants (<xref rid="fig4" ref-type="fig">Figure 4C</xref>). The results indicate that the NMJ synapses of SMN2 1-copy Smn<sup>ÎMPC</sup> mice are functional and more sensitive to acetylcholine compared to the controls. Next, we measured the eEPP by stimulating an action potential at the peroneal nerve (<xref rid="fig4" ref-type="fig">Figure 4D</xref>). Despite the increased mEPP amplitude, the amplitude of eEPPs was significantly decreased in SMN2 1-copy Smn<sup>ÎMPC</sup> mice (<xref rid="fig4" ref-type="fig">Figure 4E</xref>). These results suggest that the nerve terminals in SMN2 1-copy Smn<sup>ÎMPC</sup> mice exhibit decreased quantal content. This could be due to a decrease in vesicle release probability or a reduced readily releasable pool (RRP). Notably, there was no difference in the paired-pulse response, indicating normal neurotransmitter release probability (<xref rid="fig4" ref-type="fig">Figure 4F</xref>). Taken together, these findings suggest that the presynaptic neurotransmission ability of the NMJ is reduced in SMN2 1-copy Smn<sup>ÎMPC</sup> mutants.</p>
<fig id="fig4" position="float" orientation="portrait" fig-type="figure">
<label>Figure 4</label>
<caption><p>Reduced presynaptic neurotransmission ability in the NMJs of SMN2 1-copy Smn<sup>ÎMPC</sup> mice. <bold>(A)</bold> Representative traces of mEPP from SMN2 1-copy Smn<sup>ÎWT</sup> (top) and SMN2 1-copy Smn<sup>ÎMPC</sup> (bottom) mice. <bold>(B-C)</bold> SMN2 1-copy mutantâs NMJs showed an increase in mEPP amplitude and no differences in mEPP frequency (1-copy control, n = 25, 9 mice; 1-copy mutant, n = 21, 8 mice; Unpaired t-test with Welchâs correction). <bold>(D)</bold> Representative traces of eEPP from SMN2 1-copy Smn<sup>ÎWT</sup> (top) and SMN2 1-copy Smn<sup>ÎMPC</sup> (bottom) mice. <bold>(E)</bold> The mutantâs NMJs showed a stronger amplitude of eEPPs (1-copy control, n = 12, 4 mice; 1-copy mutant, n = 12, 3 mice; Unpaired t-test with Welchâs correction). (<bold>F</bold>) Representative traces of paired-pulse response from SMN2 1-copy Smn<sup>ÎWT</sup> (top) and SMN2 1-copy Smn<sup>ÎMPC</sup> (bottom) mice. <bold>(G)</bold> Paired-pulse response was not different between SMN2 1-copy control and mutant NMJs, indicating a comparable neurotransmitter release probability (1-copy control, n = 8, 3 mice; 1-copy mutant, n = 6, 3 mice; Unpaired t-test with Welchâs correction). The electrophysiological recording was performed in the EDL muscle at P56. ns; not significantly different. *<italic>p</italic> &lt; 0.05. All box-and-whisker plots show the median, interquartile range, minimum, and maximum.</p></caption>
<graphic xlink:href="561282v1_fig4.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s2g">
<title>Disturbed nerve terminal structure in SMN2 1-copy Smn<sup>ÎMPC</sup> mice</title>
<p>To examine the NMJ ultrastructure of SMN2 1-copy Smn<sup>ÎMPC</sup> mutants, we utilized transmission electron microscopy (TEM) (<xref rid="fig5" ref-type="fig">Figure 5A</xref>). The density of junctional folds in SMN2 1-copy Smn<sup>ÎMPC</sup> mutant specimens was comparable to that of the control (<xref rid="fig5" ref-type="fig">Figure 5B</xref>). However, the density of synaptic vesicles was substantially elevated in the SMN2 1-copy mutants (<xref rid="fig5" ref-type="fig">Figure 5C</xref>). Since previous electrophysiological results suggested a decrease in presynaptic neurotransmission capacity in SMN2 1-copy mutants, this could be due to synaptic vesicles failing to fuse with the membrane, leading to the accumulation of vesicles in the terminal. Additionally, the detachment of the nerve terminal is more frequent at the NMJ of mutants (<xref rid="fig5" ref-type="fig">Figure 5D</xref>). The detachment of nerve terminals observed in SMN2 1-copy Smn<sup>ÎMPC</sup> mutants could have resulted in diminished presynaptic neurotransmission capacity. Collectively, these findings indicate that SMN2 1-copy Smn<sup>ÎMPC</sup> mutants have nerve terminal-specific pathological defects at the NMJ ultrastructural level.</p>
<fig id="fig5" position="float" orientation="portrait" fig-type="figure">
<label>Figure 5</label>
<caption><p>Abnormal nerve terminal ultrastructure in SMN2 1-copy mutant. <bold>(A)</bold> Representative TEM images from NMJs of SMN2 1-copy Smn<sup>ÎWT</sup> and SMN2 1-copy Smn<sup>ÎMPC</sup> mice at P56. Scale bars, 500 nm. Nerve terminal (NT; indicated by the blue zone). Synaptic vesicles (SVs). Muscle fiber (MS; indicated by the red zone). Endplate junctional folds (JF). Nerve terminal detachment (indicated by arrow) was observed in SMN2 1-copy Smn<sup>ÎMPC</sup> mice. <bold>(B)</bold> The density of junctional folds in the NMJ of SMN2 1-copy Smn<sup>ÎMPC</sup> mice no significant change compared to the control, whereas (<bold>C</bold>) the density of synaptic vesicles was increased (n = 3-4 mice in each genotype; Unpaired t-test with Welchâs correction). (<bold>D</bold>) The detachment of the nerve terminal occurs more frequently at the NMJ of mutants (n = 3-4 mice in each genotype; Unpaired t-test with Welchâs correction). ns; not significantly different. *<italic>p</italic> &lt; 0.05; ***<italic>p</italic> &lt; 0.001. All box-and-whisker plots show the median, interquartile range, minimum, and maximum. For the bar graph, error bars show s.e.m.</p></caption>
<graphic xlink:href="561282v1_fig5.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s2h">
<title>FAPs transplantation rescues NMJ morphology in limb mesenchymal SMN mutants</title>
<p>SMN-deleted limb mesenchymal tissues in SMN2 1-copy Smn<sup>ÎMPC</sup> mutants comprise not only FAPs, but also bone, cartilage, pericytes, and tendon, among others (<xref ref-type="bibr" rid="c31">Leinroth et al., 2022</xref>; <xref ref-type="bibr" rid="c40">Nassari et al., 2017</xref>). To evaluate the critical role of FAPs in the postnatal development of the NMJ, we isolated fluorescent protein-labeled wild-type FAPs from <italic>Prrx1<sup>Cre</sup>; Rosa26<sup>YFP/+</sup></italic>or <italic>Prrx1<sup>Cre</sup>; Rosa26<sup>tdTomato/+</sup></italic> mice and transplanted them into the TA muscles of SMN2 1-copy Smn<sup>ÎMPC</sup> mice at postnatal day 10. The TA muscle on the contralateral side was treated with a vehicle as a control. In SMN2 1-copy Smn<sup>ÎMPC</sup> mice at P56, the muscle that received FAPs showed decreased presynaptic fragmentation, NF varicosities, and postsynaptic fragmentation compared to the contralateral muscle (<xref rid="fig6" ref-type="fig">Figure 6A-D</xref>). These data demonstrate that the transplantation of wild-type FAPs rescues the abnormal NMJ development in SMN2 1-copy Smn<sup>ÎMPC</sup> mice. Overall, our findings indicate that SMN depletion in FAPs leads to the neuronal SMN-independent NMJ pathology in severe SMA, which is rescued by the transplantation of healthy FAPs.</p>
<fig id="fig6" position="float" orientation="portrait" fig-type="figure">
<label>Figure 6</label>
<caption><p>Improved postnatal NMJ development in the TA muscle of SMN2 1-copy Smn<sup>ÎMPC</sup> mice following healthy FAPs transplantation. (<bold>A</bold>) Immunostaining of NMJs in tdTomato<sup>+</sup> FAPs-transplanted TA muscle (+FAP) and vehicle-treated contralateral muscle (+Veh) in SMN2 1-copy Smn<sup>ÎMPC</sup> mice at P56 with anti-NF (Yellow), anti-synaptophysin (Blue), Î±-Btx staining AChR (Green), and tdTomato fluorescence (Red). Scale bars, 40 Î¼m. The images revealed NF varicosities (indicated by arrowheads) in the +Veh NMJs. The tdTomato+ FAPs (marked by asterisks) were transplanted into +FAP NMJs, which exhibited (<bold>B</bold>) decreased presynaptic fragmentation, (<bold>C</bold>) NF varicosities, and (<bold>D</bold>) AChR fragmentation compared to +Veh NMJs. (n = 4 mice in each group; Unpaired t-test with Welchâs correction). ns; not significantly different. **<italic>p</italic> &lt; 0.01, ***<italic>p</italic> &lt; 0.001, ****<italic>p</italic> &lt; 0.0001. All box-and-whisker plots show the median, interquartile range, minimum, and maximum. For the bar graph, error bars show s.e.m.</p></caption>
<graphic xlink:href="561282v1_fig6.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
</sec>
<sec id="s3">
<title>Discussion</title>
<p>In this paper, we elucidate the contribution of SMN depletion in mesenchymal progenitors for the pathogenesis of SMA. To test this hypothesis, we generated conditional knockout mouse strains to delete the Smn allele specifically in limb mesenchymal cells and carry human SMN2 copies. Our research using these mouse models resulted in three major discoveries. First, SMN deficiency in FAPs contributes to NMJ pathological defects in SMA. We observed delayed NMJ maturation and varicosities in juvenile SMN2 1-copy Smn<sup>ÎMPC</sup> mutant. The pathogenic NMJ phenotypes were also observed in the SMAÎ7 mutant, which is one of the severe SMA mouse models (<xref ref-type="bibr" rid="c30">Kong et al., 2009</xref>; Martinez, 2012; <xref ref-type="bibr" rid="c25">Kariya et al., 2008</xref>). As the SMAÎ7 mutant typically lives for approximately 12 days, the fragmentation of the NMJ in adult SMN2 1-copy mutant was not evaluated in the severe SMA mutant. Nevertheless, models that induce a conditional adult SMN deficiency through either Cre<sup>ER</sup> allele or oligonucleotide administration resulting in SMN reduction, demonstrated the depletion of SMN throughout the body caused fragmentation of NMJ (<xref ref-type="bibr" rid="c47">Sahashi et al., 2013</xref>; <xref ref-type="bibr" rid="c26">Kariya et al., 2014</xref>). Thus, we demonstrate that the SMN2 1-copy Smn<sup>ÎMPC</sup> mutant model mimics whole-body SMA mouse models in NMJ morphology. In the electrophysiological test, the SMAÎ7 mutant exhibited reduced quantal content, readily releasable pool (RRP), and vesicle release probability (<xref ref-type="bibr" rid="c22">Torres-Benito et al., 2011</xref>). In our study, we did not assess RRP in SMN2 1-copy Smn<sup>ÎMPC</sup> mutant, but instead reduced quantal content and normal vesicle release probability, indicating a reduced RRP size. The decrease in RRP size in the SMAÎ7 mutant was attributed to abnormal axonal transport, which led to a decline in synaptic vesicle density in the nerve terminal (<xref ref-type="bibr" rid="c11">Dale et al., 2011</xref>; <xref ref-type="bibr" rid="c30">Kong et al., 2009</xref>). However, we found that synaptic vesicle density was increased in the SMN2 1-copy Smn<sup>ÎMPC</sup> mutant. It is possible that the alteration of active zones, which were observed in the SMA motor terminals, contributed to the reduction in synaptic vesicle fusion and the higher synaptic vesicle density. Indeed, nerve terminal detachment in SMN2 1-copy mutant mice was also found in active zone complex protein integrin-Î±3 knockout mice (<xref ref-type="bibr" rid="c46">Ross et al., 2017</xref>). Based on the rescue data of transplanted healthy FAPs, we can report that FAPs-specific SMN depletion is involved in NMJ pathology of SMA.</p>
<p>Second, we demonstrated that skeletal growth defects, a phenotype observed in SMA (<xref ref-type="bibr" rid="c27">Khatri et al., 2008</xref>; <xref ref-type="bibr" rid="c54">Vai et al., 2015</xref>; <xref ref-type="bibr" rid="c57">Wasserman et al., 2017</xref>; <xref ref-type="bibr" rid="c2">Baranello et al., 2019</xref>; <xref ref-type="bibr" rid="c18">Hensel et al., 2020</xref>), are a cell-autonomous pathological effect of the depletion of SMN in chondrocytes. We observed reduced bone size and volume in juvenile SMN2 1-copy Smn<sup>ÎMPC</sup> mutant. Depletion of SMN from chondrocytes is sufficient to cause growth problems without altering the hepatic IGF axis, which affects growth plate homeostasis. Recent studies have reported that IGF1 overexpression improves biochemical and behavioral manifestations in SMA mice, suggesting potential therapies for SMA (Bosch-Marce et al., 2011; <xref ref-type="bibr" rid="c52">Tsai et al., 2014</xref>). Our study demonstrated that these IGF1 therapies for SMA without mesenchymal SMN supplementation have a limited ability to rescue bone abnormalities. In addition, the skeletal growth defect may affect physiologic muscle atrophy through imbalanced muscle contraction and reduced tension. This physiologic atrophy may be part of SMA-associated muscle weakness independent of neurogenic atrophy.</p>
<p>Third, it was demonstrated that adequate levels of SMN protein are essential for MPCs to contribute to limb neuromusculoskeletal development. The mutants with only 1 copy of SMN2 exhibit problematic symptoms observed in both SMA patients and mouse models, while SMN2 2-copy mutants display a typical phenotype in bone and NMJ. The lack of SMN protein in MPCs by insufficient SMN2 copies, similar to the deficiency seen in severe SMA, is responsible for the onset of SMA pathology. Thus, we propose that restoration of deficient SMN in MPCs is crucial for rehabilitating their function. Based on these discoveries, SMN replenishment treatments for MPCs, specifically FAPs, and chondrocytes, are necessary to provide a complete solution for neuromusculoskeletal defects in severe SMA patients.</p>
<p>The initial focus for the treatment of SMA was on motor neurons located in the spinal cord, and pharmaceuticals were created to address the deficiency of SMN in these neurons (<xref ref-type="bibr" rid="c36">Mercuri et al., 2020</xref>). For example, intrathecal injections of Spinraza can efficiently boost SMN in the CNS, including the spinal cord (<xref ref-type="bibr" rid="c43">Passini et al., 2011</xref>; Claborn et al., 2018). However, Spinraza does not address the lack of SMN in peripheral tissues, including mesenchymal cells, highlighted in recent studies. The drug Zolgensma, which employs AAV9 to express SMN through systemic delivery, appears to resolve this issue (<xref ref-type="bibr" rid="c14">Foust et al., 2009</xref>; <xref ref-type="bibr" rid="c15">Foust et al., 2022</xref>; <xref ref-type="bibr" rid="c55">Valori et al., 2010</xref>; <xref ref-type="bibr" rid="c34">Mattar et al., 2013</xref>). Nevertheless, a prior study indicates that chondrocytes within the growth plate and articular cartilage do not get infected with AAV9 (<xref ref-type="bibr" rid="c62">Yang et al., 2019</xref>). Furthermore, it is well-established that DNA vectors delivered via AAV9 undergo dilution during cell proliferation (<xref ref-type="bibr" rid="c44">Penaud-Budloo et al., 2008</xref>; <xref ref-type="bibr" rid="c8">Colella et al., 2018</xref>; Van-Alstyne et al., 2021; <xref ref-type="bibr" rid="c17">Heller et al., 2021</xref>). Given the infection issue and the dilution issue by the active cell population changes of chondrocytes and FAPs during postnatal development (Petrany., 2020; Bachman et al., 2022), SMN supplementation through Zolgensma alone would not be sufficient for severe SMA patients. Thus, there is an urgent need to research and develop therapeutic strategies that target mesenchymal progenitors.</p>
<p>While this study is the first to demonstrate the impact of SMN depletion in FAPs on the NMJ development, it does not elucidate the specific mechanism by which FAPs influence the NMJ. Our study observed NMJ recovery in the muscles transplanted with healthy FAPs, but not in the contralateral muscles, indicating that FAPs are likely involved in NMJ development through juxtacrine or paracrine signaling. Since FAPs interact with surrounding tissues through a variety of signaling factors, such as extracellular matrix (<xref ref-type="bibr" rid="c9">Contreras et al., 2021</xref>; <xref ref-type="bibr" rid="c48">Scott et al 2019</xref>), Wnt-related protein (Lukjanenko et al., 2019), and Bmp signaling protein (<xref ref-type="bibr" rid="c53">Uezumi et al., 2021</xref>; <xref ref-type="bibr" rid="c5">Camps et al., 2020</xref>), mis-splicing of the signaling factors due to SMN reduction could disturb the homeostasis of neighboring tissues (Zhang et al., 2008). Furthermore, a population of FAPs associated with NMJ was discovered through single-cell RNA sequencing in a recent study (<xref ref-type="bibr" rid="c31">Leinroth et al., 2022</xref>). This population is located adjacent to the NMJ and responds to denervation, indicating an increased possibility of interaction with the NMJ organization. Therefore, it is necessary to conduct additional investigations into the expression of various signaling factors by diverse FAP populations in future studies.</p>
</sec>
<sec id="s4">
<title>Methods</title>
<sec id="s4a">
<title>Animals</title>
<p><italic>Prrx1<sup>Cre</sup></italic> (stock 005584), <italic>Smn<sup>f7/+</sup></italic> (stock 006138), <italic>Rosa26<sup>YFP/+</sup></italic> (stock 006148), <italic>Rosa26<sup>tdTomato/+</sup></italic>(stock 007914), <italic>SMN2</italic><sup>+/+</sup>, <italic>Smn</italic><sup>+/-</sup> (stock 005024) and <italic>Smn<sup>+/-</sup>; SMN2<sup>+/+</sup>; SMNÎ7<sup>+/+</sup></italic> (stock 005025) mice were acquired from The Jackson Laboratory (Bar Harbor, ME, USA). SMN2 0-copy Smn<sup>ÎMPC</sup> mice (<italic>Prrx1<sup>Cre</sup>; Smn<sup>f7/f7</sup></italic>), SMN2 1-copy Smn<sup>ÎMPC</sup> mice (<italic>Prrx1<sup>Cre</sup>; Smn<sup>f7/f7</sup>; SMN2<sup>+/0</sup></italic>), and SMN2 2-copy Smn<sup>ÎMPC</sup> mice (<italic>Prrx1<sup>Cre</sup>; Smn<sup>f7/f7</sup>; SMN2<sup>+/+</sup></italic>) were generated by crossing <italic>Prrx1<sup>Cre</sup></italic> mice with <italic>Smn<sup>f7/+</sup></italic>and <italic>Smn<sup>+/-</sup>; SMN2<sup>+/+</sup></italic>mice. To utilize fibro-adipogenic progenitors (FAPs) transplantation, we generated <italic>Prrx1<sup>Cre</sup>; Rosa26<sup>YFP/+</sup></italic> mice and <italic>Prrx1<sup>Cre</sup>; Rosa26<sup>tdTomato/+</sup></italic>mice by breeding <italic>Prrx1<sup>Cre</sup></italic> with <italic>Rosa26<sup>YFP/+</sup></italic> and <italic>Rosa26<sup>tdTomato/+</sup></italic> mice, respectively. To avoid deletion of the floxed allele by <italic>Prrx1<sup>Cre</sup></italic> expression in female germline, we bred females without <italic>Prrx1<sup>Cre</sup></italic> line to <italic>Prrx1<sup>Cre</sup></italic> transgenic males. SMAÎ7 mutants (<italic>Smn<sup>-/-</sup>; SMN2<sup>+/+</sup>; SMNÎ7<sup>+/+</sup></italic>) were produced by mating <italic>Smn<sup>+/-</sup>; SMN2<sup>+/+</sup>; SMNÎ7<sup>+/+</sup></italic> mice. Both male and female mice were used in the experiments, and no sex-specific differences were observed. Control littermates lacking <italic>Prrx1<sup>Cre</sup></italic> were utilized for analysis. All mouse lines were housed under controlled conditions with specific pathogen-free and handled according to the guidelines of the Seoul National University Institutional Animal Care and Use Committee (IACUC).</p>
</sec>
<sec id="s4b">
<title>Micro CT</title>
<p>The femurs from three groups - control, SMN2 2-copy Smn<sup>ÎMPC</sup>, and SMN2 1-copy Smn<sup>ÎMPC</sup> mice at postnatal day 14 (P14) - were isolated and cleaned of muscles and skin. Subsequently, the femurs were preserved in 4% paraformaldehyde (PFA) in PBS overnight at 4Â°C before micro-computed tomography (micro CT). The femurs were then imaged through a Quantum GX II micro-CT imaging system (PerkinElmer, Hopkinton, MA, USA). The X-ray source for scanning was set at 90 kV and 88 mA with a field of view of 10 mm (voxel size, 20 Î¼m; scanning time, 14 min). The 3D imaging was viewed using the 3D Viewer software of the Quantum GX II. The size and volume of the femur bone were measured via AccuCT analysis software within the ossified diaphysis and metaphysis of the femur, excluding the epiphysis. Bone mineral density (BMD) calibration was performed using a 4.5 mm BMD phantom and BMD measurements were taken at the center of the diaphysis.</p>
</sec>
<sec id="s4c">
<title>Histology</title>
<p>Alcian blue &amp; alizarin red staining was performed on control and SMN2 0-copy Smn<sup>ÎMPC</sup> mice at E18.5 using a previously reported protocol (<xref ref-type="bibr" rid="c41">Ovchinnikov, 2009</xref>). For hematoxylin &amp; eosin staining of the growth plate in the control and SMN2 1-copy Smn<sup>ÎMPC</sup> mice at P14, the femurs were fixed in 4% paraformaldehyde for 24 hours, rinsed in running tap water for 24 hours, and incubated with 10% EDTA (pH 7.4) at 4Â°C with shaking for 2-3 days. Subsequently, the samples were rinsed in running tap water for 24 hours and then dehydrated through ethanol/xylene and embedded in paraffin. The embedded samples were then sectioned to a thickness of 5 Âµm, rehydrated, and stained with Gill No. 3 formula hematoxylin and eosin Y (H&amp;E, Sigma Aldrich, St. Louis, MO, USA). Stained slides were analyzed using 10Ã and 20x objectives in the EVOS M7000 imaging system (Thermo Fisher Scientific, Waltham, MA, USA). The growth plateâs proliferative and hypertrophic zones were defined by their respective cell sizes.</p>
</sec>
<sec id="s4d">
<title>Hindlimb fibro-adipogenic progenitors isolation</title>
<p>Isolation of limb muscle FAPs was performed according to a previously reported protocol (Kim et al., 2021) with modifications. Limb muscles were dissected and mechanically dissociated in Dulbeccoâs modified Eagleâs medium (DMEM, Hyclone) containing 10% horse serum (Hyclone, Logan, UT, USA), collagenase II (800 units/mL; Worthington, Lakewood, NJ, USA), and dispase (1.1 units/mL; ThermoFisher Scientific, Waltham, MA, USA) at 37Â°C for 40 min. Digested suspensions were subsequently triturated by sterilized syringes with 20G 1/2 needle (BD Biosciences, Franklin Lakes, NJ, USA) and washed with DMEM to harvest mononuclear cells. Mononuclear cells were stained with corresponding antibodies. All antibodies used in FACS analysis were listed in Supplemental Table 1. To exclude dead cells, 7AAD (Sigma Aldrich; St. Louis, MO, USA) was used. Stained cells were analyzed and 7AAD<sup>â</sup>Lin<sup>â</sup>Vcam<sup>â</sup>Sca1<sup>+</sup> (FAPs) were isolated using FACS Aria III cell sorter (BD Biosciences) with 4-way-purity precision. For western blot, freshly isolated FAPs were cultured at 37 Â°C in alpha-MEM (Hyclone) supplemented with Antibiotic-Antimycotic (anti-anti, Gibco) and 20% FBS (Hyclone). For transplantation, YFP<sup>+</sup> FAPs and tdTomato<sup>+</sup> FAPs were isolated from postnatal day 10â¼21 <italic>Prrx1<sup>Cre</sup>; Rosa26<sup>YFP/+</sup></italic> mice and <italic>Prrx1<sup>Cre</sup>; Rosa26<sup>tdTomato/+</sup></italic>mice, respectively. Isotype control density plots were used as a reference for positive gating.</p>
</sec>
<sec id="s4e">
<title>Chondrocytes isolation</title>
<p>Isolation of chondrocytes followed a modified protocol previously published (<xref ref-type="bibr" rid="c24">Jonason et al., 2015</xref>). Using blunt forceps, cartilage caps were removed from P21 mouse femoral heads and dissected into â¼1mm fragments in a petri dish with 10X anti-anti in PBS. The cartilage fragments were washed twice with PBS and then incubated in 5 mL collagenase II solution (800 units/mL collagenase II in DMEM with 1X anti-anti, sterilized by 0.2 Âµm filtration) in a 60-mm culture dish at 37 Â°C in a 5% CO2 incubator overnight. Chondrocytes were released by pipetting the remaining cartilage fragments ten times and then filtering them through a 70 Î¼m cell strainer to a 50 ml conical tube. The cells were then washed twice with PBS and pelleted by centrifugation at 500g for 5 min. Subsequently, the cells were cultured overnight at 37 Â°C in a 5% CO2 incubator, in complete culture medium (DMEM with 10% FBS and 1X anti-anti) overnight at 37 Â°C in a 5% CO2 incubator.</p>
</sec>
<sec id="s4f">
<title>PCR reaction</title>
<p>To detect the presence of Smn exon 7 floxed and deleted allele, 20 mg of each tissue were dissolved in direct PCR buffer (VIAGEN) with proteinase K overnight at 65Â°C. After inactivation at 95Â°C for 30 minutes, PCR was performed using previously reported primer sets to verify the existence of Cre, Smn<sup>f7</sup>, and Smn<sup>Î7</sup> alleles (<xref ref-type="bibr" rid="c16">Frugier et al., 2000</xref>). Primers are listed in Supplemental Table 1.</p>
</sec>
<sec id="s4g">
<title>RNA extraction and measurement of mRNA expression</title>
<p>Total RNA was extracted from the brain, liver, spinal cord L4, tibialis anterior muscle, freshly isolated FAPs, and chondrocytes using a TRIzol Reagent (Life Technologies, Carlsbad, CA, USA) and analyzed by qRT-PCR. First-strand complementary DNA was synthesized from 1 Î¼g of RNA using ReverTra Ace (Toyobo, Osaka, Japan) containing random oligomer according to the manufacturerâs instructions. qRT-PCR (Qiagen) was performed with SYBR Green technology (SYBR Premix Ex Taq, Qiagen) using specific primers against indicated genes. Relative mRNA levels were determined using the 2<sup>-ÎÎCt</sup> method and normalized to <italic>Gapdh</italic> (<xref rid="fig1" ref-type="fig">Figure 1H</xref>, <xref rid="figs1_1" ref-type="fig">Figure 1âfigure supplement 1K</xref>). Primers are listed in Supplemental Table 1.</p>
</sec>
<sec id="s4h">
<title>Western blot</title>
<p>Cultured FAPs at passage 3 were homogenized in RIPA buffer (50 mM Tris-HCl, pH 7.5, 0.5% SDS, 20 Âµg/ mL aprotinin, 20 Âµg/ mL leupeptin, 10 Âµg/ mL phenylmethylsulfonyl fluoride, 1 mM sodium orthovanadate, 10 mM sodium pyrophosphate, 10 mM sodium fluoride, and 1 mM dithiothreitol). Cell lysates were centrifuged at 13,000 rpm for 15 min. Supernatants were collected and subjected to immunoblot. BCA protein assay (Thermo Fisher Scientific) was used for estimating total protein concentrations. Normalized total proteins were analyzed by electrophoresis in 10% polyacrylamide gels and transferred to PVDF membranes (Millipore, Billerica, MA, USA). Membranes were blocked in 5% skim milk (BD Biosciences) in TBS with 0.1% Tween-20 and incubated with primary antibodies overnight at 4Â°C. After incubation with the corresponding HRP-conjugated secondary antibodies, the membranes were developed using a Fusion solo chemiluminescence imaging system (Vilber, Marne-la-VallÃ©e, France). Î±-tubulin was used as a loading control. Band intensities were quantified using ImageJ software. Antibodies used in this study were listed in Supplemental Table 1. Primary and secondary antibodies were diluted 1:1000 and 1:10000 with PBS containing 0.1% Tween-20 and 3% BSA, respectively.</p>
</sec>
<sec id="s4i">
<title>FAPs transplantation</title>
<p>YFP<sup>+</sup> or tdTomato<sup>+</sup> FAPs were isolated by FACS from the limb muscles of indicated mice. 1Ã10<sup>5</sup> FAPs were suspended in 0.1% gelatin (Sigma Aldrich; St. Louis, MO, USA) in PBS and then transplanted into one side of the TA muscles of SMN2 1-copy Smn<sup>ÎMPC</sup> mice. The contralateral muscle received an equivalent volume of 0.1% gelatin in PBS (Vehicle).</p>
</sec>
<sec id="s4j">
<title>Electrophysiology</title>
<p>The extensor digitorum longus (EDL) muscle was dissected from control and SMN2 1-copy Smn<sup>ÎMPC</sup> mice, along with the peroneal nerve, and then pinned to a Sylgard-coated recording chamber. Intracellular recording was conducted in oxygenated Ringerâs solution, which comprised 138.8 mM NaCl, 4 mM KCl, 12 mM NaHCO3, 1 mM KH2PO4, 1 mM MgCl2 and 2 mM CaCl2 with a pH of 7.4. Action potential of the muscle was prevented by preparing the muscle in 2.5 uM Î¼-conotoxin GIIB (Alomone, Jerusalem, Israel) for 10 minutes beforehand. The recording was performed in toxin-free Ringerâs solution. Miniature endplate potentials (mEPPs) were recorded from a junction, followed by recordings of evoked endplate potentials (eEPPs) by stimulating the attached peroneal nerve. The eEPPs were elicited using evoked stimulation. Paired-pulse stimulation (10 ms inter-stimulus interval) was utilized to assess synaptic transmission. The data was obtained and analyzed with Axoclamp 900A and Clampfit version 10.7 software.</p>
</sec>
<sec id="s4k">
<title>Transmission electron microscopy</title>
<p>NMJ transmission electron microscopy followed a modified protocol previously reported (<xref ref-type="bibr" rid="c37">Modla et al., 2010</xref>). Mouse EDL muscle was swiftly excised and fixed in 4% paraformaldehyde (PFA) dissolved in Sorensenâs phosphate buffer (0.1M, pH 7.2), followed by washing in 0.1 M phosphate buffer. The EDL was then gradually infiltrated on a rotator at room temperature with sucrose: 0.1M phosphate buffer solutions of 30% and 50%, for one hour each, followed by an overnight incubation in 70% sucrose. Excess sucrose was then eliminated using filter paper, and the muscle was embedded in an optimal cutting temperature compound (O.C.T.; Sakura Fineteck, Torrance, CA, USA), followed by being frozen in a cryostat (Leica, Wetzlar, Germany). 10-Âµm thick longitudinal sections were washed in PBS and treated with Alexa fluor 555-conjugated Î±-bungarotoxin (1:500, Invitrogen) for an hour. Imaging was conducted with the EVOS M7000 imaging system, and we selected 4-5 NMJ-rich regions for processing with TEM. The sections were fixed with 2% glutaraldehyde and 2% PFA in 0.1M cacodylate buffer (pH 7.2) for two hours at room temperature, with an additional overnight incubation at 4â. After washing with 0.1M cacodylate buffer they were post-fixed with 1% osmium tetraoxide in 0.1M cacodylate buffer (pH 7.2)- for two hours at 4Â°C. The sections were then stained en bloc with 0.5% uranyl acetate overnight, washed with distilled water, and dehydrated using serial ethanol and propylene oxide. The sections were embedded in epoxy resin (Embed-812, Electron Microscopy Sciences) and detached from the slides by dipping them in liquid nitrogen. Ultra-thin sections (70nm) were prepared with a diamond knife on an ultramicrotome (ULTRACUT UC7, Leica) and mounted on 100 mesh copper grids. Sections were stained with 2% uranyl acetate for 10 minutes and lead citrate for 3 minutes, then observed using a transmission electron microscope (80kV, JEM1010, JEOL or 120kV, Talos L120C, FEI). Synaptic vesicle density was quantified within a distance of 500 nm from the presynaptic membrane.</p>
</sec>
<sec id="s4l">
<title>Immunohistochemistry</title>
<p>Freshly dissected TA muscles were fixed in 4% PFA for 30 min at room temperature. Subsequently, the muscles were cryoprotected in 30% sucrose overnight, embedded in O.C.T., snap-frozen in liquid nitrogen, and stored at -80Â°C prior to sectioning. Longitudinal 40 Î¼m-thick sections were obtained from the embedded muscles using a cryostat. The sections were blocked for 2 hours at room temperature using 5% goat serum and 5% bovine serum albumin in PBS/0.4% Triton X-100. Then, the sections were incubated with primary antibodies in the blocking buffer for two days at 4 Â°C. After washing the sections three times with PBS/0.4% Triton X-100, the sections were stained with secondary antibodies overnight at 4 Â°C, and then incubated with Alexa fluor 488 or 555-conjugated Î±-bungarotoxin (1:500, Invitrogen) for 2hr at RT, washed three times with PBS/0.4% Triton X-100 and mounted in VECTASHIELD. Z-serial images were collected at 40X with a Leica SP8 confocal laser scanning microscope. To analyze NMJ morphology, LasX software was used to obtain maximal projections. Neurofilament (NF) varicosity refers to the varicose NF end connected to the rest of the nerve terminal. To quantify NMJ size and synaptophysin coverage, the Btx area and synaptophysin area were measured by ImageJ analysis software.</p>
</sec>
<sec id="s4m">
<title>Statistical analysis</title>
<p>All statistical analyses were performed using GraphPad Prism 9 (GraphPad Software). For comparison of significant differences in multiple groups for normally distributed data, statistical analysis was performed by one-way or two-way ANOVA followed by Tukeyâs pairwise comparison post hoc test. For non-normally distributed data, BrownâForsythe and Welch ANOVA followed by Games-Howell multiple comparisons test was used. For the comparison of two groups, Studentâs unpaired t-test assuming a two-tailed distribution with Welchâs correction was used. Unless otherwise noted, all error bars represent s.e.m. The number of biological replicates and statistical analyses for each experiment were indicated in the figure legends. Independent experiments were performed at least in triplicates. P &lt; 0.05 was considered statistically significant at the 95% confidence level. *<italic>p</italic> &lt; 0.05, **<italic>p</italic> &lt; 0.01, ***<italic>p</italic> &lt; 0.001, ****<italic>p</italic> &lt; 0.0001.</p>
</sec>
</sec>
</body>
<back>
<sec id="s5">
<title>Supplemental information</title>
<p>Supplemental information includes one Supplementary Table.</p>
</sec>
<sec id="s6">
<title>Ethics</title>
<p>The care and treatment of animals were approved by the IACUC of Seoul National University.</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>We express our gratitude to the Kong and Choi laboratory members for their valuable feedback during the project. This work was supported by the National Research Foundation of Korea (NRF-2022R1A2C3007621 and NRF-2020R1A5A1018081).</p>
</ack>
<ref-list>
<title>References</title>
<ref id="c1"><mixed-citation publication-type="journal"><string-name><surname>Bachman</surname>, <given-names>J. F.</given-names></string-name>, &amp; <string-name><surname>Chakkalakal</surname>, <given-names>J. V</given-names></string-name>. (<year>2022</year>). <article-title>Insights into muscle stem cell dynamics during postnatal development</article-title>. <source>FEBS Journal</source>, <volume>289</volume>(<issue>10</issue>), <fpage>2710</fpage>â<lpage>2722</lpage>. <pub-id pub-id-type="doi">10.1111/febs.15856</pub-id></mixed-citation></ref>
<ref id="c2"><mixed-citation publication-type="journal"><string-name><surname>Baranello</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Vai</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Broggi</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Masson</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Arnoldi</surname>, <given-names>M. T.</given-names></string-name>, <string-name><surname>Zanin</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Mastella</surname>, <given-names>C.</given-names></string-name>, &amp; <string-name><surname>Bianchi</surname>, <given-names>M. L</given-names></string-name>. (<year>2019</year>). <article-title>Evolution of bone mineral density, bone metabolism and fragility fractures in Spinal Muscular Atrophy (SMA) types 2 and 3</article-title>. <source>Neuromuscular Disorders</source>, <volume>29</volume>(<issue>7</issue>), <fpage>525</fpage>â<lpage>532</lpage>. <pub-id pub-id-type="doi">10.1016/j.nmd.2019.06.001</pub-id></mixed-citation></ref>
<ref id="c3"><mixed-citation publication-type="journal"><string-name><surname>Besse</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Astord</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Marais</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Roda</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Giroux</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Lejeune</surname>, <given-names>F. X.</given-names></string-name>, <string-name><surname>Relaix</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Smeriglio</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Barkats</surname>, <given-names>M.</given-names></string-name>, &amp; <string-name><surname>Biferi</surname>, <given-names>M. G</given-names></string-name>. (<year>2020</year>). <article-title>AAV9-Mediated Expression of SMN Restricted to Neurons Does Not Rescue the Spinal Muscular Atrophy Phenotype in Mice</article-title>. <source>Molecular Therapy</source>, <volume>28</volume>(<issue>8</issue>), <fpage>1887</fpage>â<lpage>1901</lpage>. <pub-id pub-id-type="doi">10.1016/j.ymthe.2020.05.011</pub-id></mixed-citation></ref>
<ref id="c4"><mixed-citation publication-type="journal"><string-name><surname>Bosch-MarcÃ©</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Wee</surname>, <given-names>C. D.</given-names></string-name>, <string-name><surname>Martinez</surname>, <given-names>T. L.</given-names></string-name>, <string-name><surname>Lipkes</surname>, <given-names>C. E.</given-names></string-name>, <string-name><surname>Choe</surname>, <given-names>D. W.</given-names></string-name>, <string-name><surname>Kong</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Van Meerbeke</surname>, <given-names>J. P.</given-names></string-name>, <string-name><surname>MusarÃ²</surname>, <given-names>A.</given-names></string-name>, &amp; <string-name><surname>Sumner</surname>, <given-names>C. J.</given-names></string-name> (<year>2011</year>). <article-title>Increased IGF-1 in muscle modulates the phenotype of severe SMA mice</article-title>. <source>Human Molecular Genetics</source>, <volume>20</volume>(<issue>9</issue>), <fpage>1844</fpage>â<lpage>1853</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddr067</pub-id></mixed-citation></ref>
<ref id="c5"><mixed-citation publication-type="journal"><string-name><surname>Camps</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Breuls</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Sifrim</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Giarratana</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Corvelyn</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Danti</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Grosemans</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Vanuytven</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Thiry</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Belicchi</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Meregalli</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Platko</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>MacDonald</surname>, <given-names>M. E.</given-names></string-name>, <string-name><surname>Austin</surname>, <given-names>R. C.</given-names></string-name>, <string-name><surname>Gijsbers</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Cossu</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Torrente</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Voet</surname>, <given-names>T.</given-names></string-name>, &amp; <string-name><surname>Sampaolesi</surname>, <given-names>M</given-names></string-name>. (<year>2020</year>). <article-title>Interstitial Cell Remodeling Promotes Aberrant Adipogenesis in Dystrophic Muscles</article-title>. <source>Cell Reports</source>, <volume>31</volume>(<issue>5</issue>), <fpage>107597</fpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2020.107597</pub-id></mixed-citation></ref>
<ref id="c6"><mixed-citation publication-type="journal"><string-name><surname>Cifuentes-Diaz</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Frugier</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Tiziano</surname>, <given-names>F. D.</given-names></string-name>, <string-name><surname>LacÃ¨ne</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Roblot</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Joshi</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Moreau</surname>, <given-names>M. H.</given-names></string-name>, &amp; <string-name><surname>Melki</surname>, <given-names>J</given-names></string-name>. (<year>2001</year>). <article-title>Deletion of murine SMN exon 7 directed to skeletal muscle leads to severe muscular dystrophy</article-title>. <source>Journal of Cell Biology</source>, <volume>152</volume>(<issue>5</issue>), <fpage>1107</fpage>â<lpage>1114</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.152.5.1107</pub-id></mixed-citation></ref>
<ref id="c7"><mixed-citation publication-type="journal"><string-name><surname>Claborn</surname>, <given-names>M. K.</given-names></string-name>, <string-name><surname>Stevens</surname>, <given-names>D. L.</given-names></string-name>, <string-name><surname>Walker</surname>, <given-names>C. K.</given-names></string-name>, &amp; <string-name><surname>Gildon</surname>, <given-names>B. L</given-names></string-name>. (<year>2019</year>). <article-title>Nusinersen: A Treatment for Spinal Muscular Atrophy</article-title>. <source>Annals of Pharmacotherapy</source>, <volume>53</volume>(<issue>1</issue>), <fpage>61</fpage>â<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1177/1060028018789956</pub-id></mixed-citation></ref>
<ref id="c8"><mixed-citation publication-type="journal"><string-name><surname>Colella</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Ronzitti</surname>, <given-names>G.</given-names></string-name>, &amp; <string-name><surname>Mingozzi</surname>, <given-names>F</given-names></string-name>. (<year>2018</year>). <article-title>Emerging Issues in AAV-Mediated In Vivo Gene Therapy</article-title>. <source>Molecular Therapy - Methods and Clinical Development</source>, <volume>8</volume>(<issue>March</issue>), <fpage>87</fpage>â<lpage>104</lpage>. <pub-id pub-id-type="doi">10.1016/j.omtm.2017.11.007</pub-id></mixed-citation></ref>
<ref id="c9"><mixed-citation publication-type="journal"><string-name><surname>Contreras</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Rossi</surname>, <given-names>F. M. V.</given-names></string-name>, &amp; <string-name><surname>Theret</surname>, <given-names>M</given-names></string-name>. (<year>2021</year>). <article-title>Origins, potency, and heterogeneity of skeletal muscle fibro-adipogenic progenitorsâtime for new definitions</article-title>. <source>Skeletal Muscle</source>, <volume>11</volume>(<issue>1</issue>), <fpage>1</fpage>â<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1186/s13395-021-00265-6</pub-id></mixed-citation></ref>
<ref id="c10"><mixed-citation publication-type="journal"><string-name><surname>Currie</surname>, <given-names>J. D.</given-names></string-name>, <string-name><surname>Grosser</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Murawala</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Schuez</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Michel</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Tanaka</surname>, <given-names>E. M.</given-names></string-name>, &amp; <string-name><surname>Sandoval-Guzman</surname>, <given-names>T</given-names></string-name>. (<year>2019</year>). <article-title>The Prrx1 limb enhancer marks an adult subpopulation of injury-responsive dermal fibroblasts</article-title>. <source>Biology Open</source>, <volume>8</volume>(<issue>7</issue>), <fpage>1</fpage>â<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1242/bio.043711</pub-id></mixed-citation></ref>
<ref id="c11"><mixed-citation publication-type="journal"><string-name><surname>Dale</surname>, <given-names>J. M.</given-names></string-name>, <string-name><surname>Shen</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Barry</surname>, <given-names>D. M.</given-names></string-name>, <string-name><surname>Garcia</surname>, <given-names>V. B.</given-names></string-name>, <string-name><surname>Rose</surname>, <given-names>F. F.</given-names></string-name>, <string-name><surname>Lorson</surname>, <given-names>C. L.</given-names></string-name>, &amp; <string-name><surname>Garcia</surname>, <given-names>M. L</given-names></string-name>. (<year>2011</year>). <article-title>The spinal muscular atrophy mouse model, SMAÎ7, displays altered axonal transport without global neurofilament alterations</article-title>. <source>Acta Neuropathologica</source>, <volume>122</volume>(<issue>3</issue>), <fpage>331</fpage>â<lpage>341</lpage>. <pub-id pub-id-type="doi">10.1007/s00401-011-0848-5</pub-id></mixed-citation></ref>
<ref id="c12"><mixed-citation publication-type="journal"><string-name><surname>Deguise</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Pileggi</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Repentigny</surname>, <given-names>Y. De</given-names></string-name>, <string-name><surname>Beauvais</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Tierney</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Chehade</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Michaud</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Llavero-hurtado</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Lamont</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Atrih</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Wishart</surname>, <given-names>T. M.</given-names></string-name>, <string-name><surname>Gillingwater</surname>, <given-names>T. H.</given-names></string-name>, <string-name><surname>Schneider</surname>, <given-names>B. L.</given-names></string-name>, <string-name><surname>Harper</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Parson</surname>, <given-names>S. H.</given-names></string-name>, &amp; <string-name><surname>Kothary</surname>, <given-names>R.</given-names></string-name> (<year>2021</year>). <article-title>SMN Depleted Mice Offer a Robust and Rapid Onset Model of</article-title>. <source>Cellular and Molecular Gastroenterology and Hepatology</source>, <volume>12</volume>(<issue>1</issue>), <fpage>354</fpage>â<lpage>377</lpage>.e3. <pub-id pub-id-type="doi">10.1016/j.jcmgh.2021.01.019</pub-id></mixed-citation></ref>
<ref id="c13"><mixed-citation publication-type="journal"><string-name><surname>Deschenes</surname>, <given-names>M. R.</given-names></string-name>, <string-name><surname>Tenny</surname>, <given-names>K. A.</given-names></string-name>, &amp; <string-name><surname>Wilson</surname>, <given-names>M. H</given-names></string-name>. (<year>2006</year>). <article-title>Increased and decreased activity elicits specific morphological adaptations of the neuromuscular junction</article-title>. <source>Neuroscience</source>, <volume>137</volume>(<issue>4</issue>), <fpage>1277</fpage>â<lpage>1283</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2005.10.042</pub-id></mixed-citation></ref>
<ref id="c14"><mixed-citation publication-type="journal"><string-name><surname>Foust</surname>, <given-names>K. D.</given-names></string-name>, <string-name><surname>Nurre</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Montgomery</surname>, <given-names>C. L.</given-names></string-name>, <string-name><surname>Hernandez</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Chan</surname>, <given-names>C. M.</given-names></string-name>, &amp; <string-name><surname>Kaspar</surname>, <given-names>B. K</given-names></string-name>. (<year>2009</year>). <article-title>Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes</article-title>. <source>Nature Biotechnology</source>, <volume>27</volume>(<issue>1</issue>), <fpage>59</fpage>â<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1038/nbt.1515</pub-id></mixed-citation></ref>
<ref id="c15"><mixed-citation publication-type="journal"><string-name><surname>Foust</surname>, <given-names>K. D.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>McGovern</surname>, <given-names>V. L.</given-names></string-name>, <string-name><surname>Braun</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Bevan</surname>, <given-names>A. K.</given-names></string-name>, <string-name><surname>Haidet</surname>, <given-names>A. M.</given-names></string-name>, <string-name><surname>Le</surname>, <given-names>T. T.</given-names></string-name>, <string-name><surname>Morales</surname>, <given-names>P. R.</given-names></string-name>, <string-name><surname>Rich</surname>, <given-names>M. M.</given-names></string-name>, <string-name><surname>Burghes</surname>, <given-names>A. H. M.</given-names></string-name>, &amp; <string-name><surname>Kaspar</surname>, <given-names>B. K</given-names></string-name>. (<year>2022</year>). <article-title>Retraction Note: Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN</article-title>. <source>Nature Biotechnology</source>, <volume>40</volume>(<issue>11</issue>), <fpage>1692</fpage>â<lpage>1692</lpage>. <pub-id pub-id-type="doi">10.1038/s41587-022-01497-7</pub-id></mixed-citation></ref>
<ref id="c16"><mixed-citation publication-type="journal"><string-name><surname>Frugier</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Tiziano</surname>, <given-names>F. D.</given-names></string-name>, <string-name><surname>Cifuentes-Diaz</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Miniou</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Roblot</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Dierich</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Le Meur</surname>, <given-names>M.</given-names></string-name>, &amp; <string-name><surname>Melki</surname>, <given-names>J.</given-names></string-name> (<year>2000</year>). <article-title>Nuclear targeting defect of SMN lacking the C-terminus in a mouse model of spinal muscular atrophy</article-title>. <source>Human Molecular Genetics</source>, <volume>9</volume>(<issue>5</issue>), <fpage>849</fpage>â<lpage>858</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/9.5.849</pub-id></mixed-citation></ref>
<ref id="c17"><mixed-citation publication-type="journal"><string-name><surname>Heller</surname>, <given-names>G. J.</given-names></string-name>, <string-name><surname>Marshall</surname>, <given-names>M. S.</given-names></string-name>, <string-name><surname>Issa</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Marshall</surname>, <given-names>J. N.</given-names></string-name>, <string-name><surname>Nguyen</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Rue</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Pathmasiri</surname>, <given-names>K. C.</given-names></string-name>, <string-name><surname>Domowicz</surname>, <given-names>M. S.</given-names></string-name>, <string-name><surname>van Breemen</surname>, <given-names>R. B.</given-names></string-name>, <string-name><surname>Tai</surname>, <given-names>L. M.</given-names></string-name>, <string-name><surname>Cologna</surname>, <given-names>S. M.</given-names></string-name>, <string-name><surname>Crocker</surname>, <given-names>S. J.</given-names></string-name>, <string-name><surname>Givogri</surname>, <given-names>M. I.</given-names></string-name>, <string-name><surname>Sands</surname>, <given-names>M. S.</given-names></string-name>, &amp; <string-name><surname>Bongarzone</surname>, <given-names>E. R.</given-names></string-name> (<year>2021</year>). <article-title>Waning efficacy in a long-term AAV-mediated gene therapy study in the murine model of Krabbe disease</article-title>. <source>Molecular Therapy</source>, <volume>29</volume>(<issue>5</issue>), <fpage>1883</fpage>â<lpage>1902</lpage>. <pub-id pub-id-type="doi">10.1016/j.ymthe.2021.01.026</pub-id></mixed-citation></ref>
<ref id="c18"><mixed-citation publication-type="journal"><string-name><surname>Hensel</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Brickwedde</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Tsaknakis</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Grages</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Braunschweig</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>LÃ¼ders</surname>, <given-names>K. A.</given-names></string-name>, <string-name><surname>Lorenz</surname>, <given-names>H. M.</given-names></string-name>, <string-name><surname>Lippross</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Walter</surname>, <given-names>L. M.</given-names></string-name>, <string-name><surname>Tavassol</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Lienenklaus</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Neunaber</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Claus</surname>, <given-names>P.</given-names></string-name>, &amp; <string-name><surname>Hell</surname>, <given-names>A. K</given-names></string-name>. (<year>2020</year>). <article-title>Altered bone development with impaired cartilage formation precedes neuromuscular symptoms in spinal muscular atrophy</article-title>. <source>Human Molecular Genetics</source>, <volume>29</volume>(<issue>16</issue>), <fpage>2662</fpage>â<lpage>2673</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddaa145</pub-id></mixed-citation></ref>
<ref id="c19"><mixed-citation publication-type="journal"><string-name><surname>Hoxha</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Islami</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>QorrajBytyqi</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Thaci</surname>, <given-names>S.</given-names></string-name>, &amp; <string-name><surname>Bahtiri</surname>, <given-names>E</given-names></string-name>. (<year>2014</year>). <article-title>Relationship of Weight and Body Mass Index with Bone Mineral Density in Adult Men from Kosovo</article-title>. <source>Materia Socio Medica</source>, <volume>26</volume>(<issue>5</issue>), <fpage>306</fpage>. <pub-id pub-id-type="doi">10.5455/msm.2014.26.306-308</pub-id></mixed-citation></ref>
<ref id="c20"><mixed-citation publication-type="journal"><string-name><surname>Hua</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Sahashi</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Rigo</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Hung</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Horev</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Bennett</surname>, <given-names>C. F.</given-names></string-name>, &amp; <string-name><surname>Krainer</surname>, <given-names>A. R</given-names></string-name>. (<year>2011</year>). <article-title>Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model</article-title>. <source>Nature</source>, <volume>478</volume>(<issue>7367</issue>), <fpage>123</fpage>â<lpage>126</lpage>. <pub-id pub-id-type="doi">10.1038/nature10485</pub-id></mixed-citation></ref>
<ref id="c21"><mixed-citation publication-type="journal"><string-name><surname>Passini</surname>, <given-names>M. A.</given-names></string-name>, <string-name><surname>Bu</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Roskelley</surname>, <given-names>E. M.</given-names></string-name>, <string-name><surname>Richards</surname>, <given-names>A. M.</given-names></string-name>, <string-name><surname>Sardi</surname>, <given-names>S. P.</given-names></string-name>, <string-name><surname>OâRiordan</surname>, <given-names>C. R.</given-names></string-name>, <string-name><surname>Klinger</surname>, <given-names>K. W.</given-names></string-name>, <string-name><surname>Shihabuddin</surname>, <given-names>L. S.</given-names></string-name>, &amp; <string-name><surname>Cheng</surname>, <given-names>S. H</given-names></string-name>. (<year>2010</year>). <article-title>CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy</article-title>. <source>Journal of Clinical Investigation</source>, <volume>120</volume>(<issue>4</issue>), <fpage>1253</fpage>â<lpage>1264</lpage>. <pub-id pub-id-type="doi">10.1172/JCI41615</pub-id></mixed-citation></ref>
<ref id="c22"><mixed-citation publication-type="journal"><string-name><surname>Torres-Benito</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Neher</surname>, <given-names>M. F.</given-names></string-name>, <string-name><surname>Cano</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Ruiz</surname>, <given-names>R.</given-names></string-name>, &amp; <string-name><surname>Tabares</surname>, <given-names>L</given-names></string-name>. (<year>2011</year>). <article-title>SMN requirement for synaptic vesicle, active zone and microtubule postnatal organization in motor nerve terminals</article-title>. <source>PLoS ONE</source>, <volume>6</volume>(<fpage>10</fpage>). <pub-id pub-id-type="doi">10.1371/journal.pone.0026164</pub-id></mixed-citation></ref>
<ref id="c23"><mixed-citation publication-type="journal"><string-name><surname>Ike</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Inaba</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Kobayashi</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Hirata</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Yukizawa</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Aoki</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Choe</surname>, <given-names>H.</given-names></string-name>, &amp; <string-name><surname>Saito</surname>, <given-names>T</given-names></string-name>. (<year>2015</year>). <article-title>Comparison between mechanical stress and bone mineral density in the femur after total hip arthroplasty by using subject-specific finite element analyses</article-title>. <source>Computer Methods in Biomechanics and Biomedical Engineering</source>, <volume>18</volume>(<issue>10</issue>), <fpage>1056</fpage>â<lpage>1065</lpage>. <pub-id pub-id-type="doi">10.1080/10255842.2013.869320</pub-id></mixed-citation></ref>
<ref id="c24"><mixed-citation publication-type="journal"><string-name><surname>Jonason</surname>, <given-names>J. H.</given-names></string-name>, <string-name><surname>Hoak</surname>, <given-names>D.</given-names></string-name>, &amp; <string-name><surname>OâKeefe</surname>, <given-names>R. J</given-names></string-name>. (<year>2015</year>). <article-title>Primary Murine Growth Plate and Articular Chondrocyte Isolation and Cell Culture</article-title>. <source>In Osteoporosis and Osteoarthritis</source> (Vol. <volume>1226</volume>, pp. <fpage>11</fpage>â<lpage>18</lpage>). <pub-id pub-id-type="doi">10.1007/978-1-4939-1619-1_2</pub-id></mixed-citation></ref>
<ref id="c25"><mixed-citation publication-type="journal"><string-name><surname>Kariya</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Park</surname>, <given-names>G. H.</given-names></string-name>, <string-name><surname>Maeno-Hikichi</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Leykekhman</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Lutz</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Arkovitz</surname>, <given-names>M. S.</given-names></string-name>, <string-name><surname>Landmesser</surname>, <given-names>L. T.</given-names></string-name>, &amp; <string-name><surname>Monani</surname>, <given-names>U. R</given-names></string-name>. (<year>2008</year>). <article-title>Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy</article-title>. <source>Human Molecular Genetics</source>, <volume>17</volume>(<issue>16</issue>), <fpage>2552</fpage>â<lpage>2569</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddn156</pub-id></mixed-citation></ref>
<ref id="c26"><mixed-citation publication-type="journal"><string-name><surname>Kariya</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Obis</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Garone</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Akay</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Sera</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Iwata</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Homma</surname>, <given-names>S.</given-names></string-name>, &amp; <string-name><surname>Monani</surname>, <given-names>U. R</given-names></string-name>. (<year>2014</year>). <article-title>Requirement of enhanced Survival Motoneuron protein imposed during neuromuscular junction maturation</article-title>. <source>Journal of Clinical Investigation</source>, <volume>124</volume>(<issue>2</issue>), <fpage>785</fpage>â<lpage>800</lpage>. <pub-id pub-id-type="doi">10.1172/JCI72017</pub-id></mixed-citation></ref>
<ref id="c27"><mixed-citation publication-type="journal"><string-name><surname>Khatri</surname>, <given-names>I. A.</given-names></string-name>, <string-name><surname>Chaudhry</surname>, <given-names>U. S.</given-names></string-name>, <string-name><surname>Seikaly</surname>, <given-names>M. G.</given-names></string-name>, <string-name><surname>Browne</surname>, <given-names>R. H.</given-names></string-name>, &amp; <string-name><surname>Iannaccone</surname>, <given-names>S. T</given-names></string-name>. (<year>2008</year>). <article-title>Low bone mineral density in spinal muscular atrophy</article-title>. <source>Journal of Clinical Neuromuscular Disease</source>, <volume>10</volume>(<issue>1</issue>), <fpage>11</fpage>â<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1097/CND.0b013e318183e0fa</pub-id></mixed-citation></ref>
<ref id="c28"><mixed-citation publication-type="journal"><string-name><surname>Kim</surname>, <given-names>J. K.</given-names></string-name>, <string-name><surname>Jha</surname>, <given-names>N. N.</given-names></string-name>, <string-name><surname>Feng</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Faleiro</surname>, <given-names>M. R.</given-names></string-name>, <string-name><surname>Chiriboga</surname>, <given-names>C. A.</given-names></string-name>, <string-name><surname>Wei-Lapierre</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Dirksen</surname>, <given-names>R. T.</given-names></string-name>, <string-name><surname>Ko</surname>, <given-names>C. P.</given-names></string-name>, &amp; <string-name><surname>Monani</surname>, <given-names>U. R</given-names></string-name>. (<year>2020</year>). <article-title>Muscle-specific SMN reduction reveals motor neuronâindependent disease in spinal muscular atrophy models</article-title>. <source>Journal of Clinical Investigation</source>, <volume>130</volume>(<issue>3</issue>), <fpage>1271</fpage>â<lpage>1287</lpage>. <pub-id pub-id-type="doi">10.1172/JCI131989</pub-id></mixed-citation></ref>
<ref id="c29"><mixed-citation publication-type="journal"><string-name><surname>Kim</surname>, <given-names>J. H.</given-names></string-name>, <string-name><surname>Kang</surname>, <given-names>J. S.</given-names></string-name>, <string-name><surname>Yoo</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Jeong</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Park</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Park</surname>, <given-names>J. H.</given-names></string-name>, <string-name><surname>Rhee</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Jeon</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Jo</surname>, <given-names>Y. W.</given-names></string-name>, <string-name><surname>Hann</surname>, <given-names>S. H.</given-names></string-name>, <string-name><surname>Seo</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Moon</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Um</surname>, <given-names>S. J.</given-names></string-name>, <string-name><surname>Seong</surname>, <given-names>R. H.</given-names></string-name>, &amp; <string-name><surname>Kong</surname>, <given-names>Y. Y</given-names></string-name>. (<year>2022</year>). <article-title>Bap1/SMN axis in Dpp4+ skeletal muscle mesenchymal cells regulates the neuromuscular system</article-title>. <source>JCI Insight</source>, <volume>7</volume>(<fpage>10</fpage>). <pub-id pub-id-type="doi">10.1172/jci.insight.158380</pub-id></mixed-citation></ref>
<ref id="c30"><mixed-citation publication-type="journal"><string-name><surname>Kong</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Choe</surname>, <given-names>D. W.</given-names></string-name>, <string-name><surname>Polley</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Burnett</surname>, <given-names>B. G.</given-names></string-name>, <string-name><surname>Bosch-MarcÃ©</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Griffin</surname>, <given-names>J. W.</given-names></string-name>, <string-name><surname>Rich</surname>, <given-names>M. M.</given-names></string-name>, &amp; <string-name><surname>Sumner</surname>, <given-names>C. J</given-names></string-name>. (<year>2009</year>). <article-title>Impaired synaptic vesicle release and immaturity of neuromuscular junctions in spinal muscular atrophy mice</article-title>. <source>Journal of Neuroscience</source>, <volume>29</volume>(<issue>3</issue>), <fpage>842</fpage>â<lpage>851</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4434-08.2009</pub-id></mixed-citation></ref>
<ref id="c31"><mixed-citation publication-type="journal"><string-name><surname>Leinroth</surname>, <given-names>A. P.</given-names></string-name>, <string-name><surname>Mirando</surname>, <given-names>A. J.</given-names></string-name>, <string-name><surname>Rouse</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Kobayahsi</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Tata</surname>, <given-names>P. R.</given-names></string-name>, <string-name><surname>Rueckert</surname>, <given-names>H. E.</given-names></string-name>, <string-name><surname>Liao</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Long</surname>, <given-names>J. T.</given-names></string-name>, <string-name><surname>Chakkalakal</surname>, <given-names>J. V.</given-names></string-name>, &amp; <string-name><surname>Hilton</surname>, <given-names>M. J</given-names></string-name>. (<year>2022</year>). <article-title>Identification of distinct non-myogenic skeletal-muscle-resident mesenchymal cell populations</article-title>. <source>Cell Reports</source>, <volume>39</volume>(<issue>6</issue>), <fpage>110785</fpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2022.110785</pub-id></mixed-citation></ref>
<ref id="c32"><mixed-citation publication-type="journal"><string-name><surname>Ling</surname>, <given-names>K. K. Y.</given-names></string-name>, <string-name><surname>Lin</surname>, <given-names>M. Y.</given-names></string-name>, <string-name><surname>Zingg</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Feng</surname>, <given-names>Z.</given-names></string-name>, &amp; <string-name><surname>Ko</surname>, <given-names>C. P</given-names></string-name>. (<year>2010</year>). <article-title>Synaptic defects in the spinal and neuromuscular circuitry in a mouse model of spinal muscular atrophy</article-title>. <source>PLoS ONE</source>, <volume>5</volume>(<fpage>11</fpage>). <pub-id pub-id-type="doi">10.1371/journal.pone.0015457</pub-id></mixed-citation></ref>
<ref id="c33"><mixed-citation publication-type="journal"><string-name><surname>Martinez</surname>, <given-names>T. L.</given-names></string-name>, <string-name><surname>Kong</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Osborne</surname>, <given-names>M. A.</given-names></string-name>, <string-name><surname>Crowder</surname>, <given-names>M. E.</given-names></string-name>, <string-name><surname>Van Meerbeke</surname>, <given-names>J. P.</given-names></string-name>, <string-name><surname>Xu</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Davis</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Wooley</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Goldhamer</surname>, <given-names>D. J.</given-names></string-name>, <string-name><surname>Lutz</surname>, <given-names>C. M.</given-names></string-name>, <string-name><surname>Rich</surname>, <given-names>M. M.</given-names></string-name>, &amp; <string-name><surname>Sumner</surname>, <given-names>C. J.</given-names></string-name> (<year>2012</year>). <article-title>Survival Motor Neuron Protein in Motor Neurons Determines Synaptic Integrity in Spinal Muscular Atrophy</article-title>. <source>Journal of Neuroscience</source>, <volume>32</volume>(<issue>25</issue>), <fpage>8703</fpage>â<lpage>8715</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0204-12.2012</pub-id></mixed-citation></ref>
<ref id="c34"><mixed-citation publication-type="journal"><string-name><surname>Mattar</surname>, <given-names>C. N.</given-names></string-name>, <string-name><surname>Waddington</surname>, <given-names>S. N.</given-names></string-name>, <string-name><surname>Biswas</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Johana</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Ng</surname>, <given-names>X. W.</given-names></string-name>, <string-name><surname>Fisk</surname>, <given-names>A. S.</given-names></string-name>, <string-name><surname>Fisk</surname>, <given-names>N. M.</given-names></string-name>, <string-name><surname>Tan</surname>, <given-names>L. G.</given-names></string-name>, <string-name><surname>Rahim</surname>, <given-names>A. A.</given-names></string-name>, <string-name><surname>Buckley</surname>, <given-names>S. M. K.</given-names></string-name>, <string-name><surname>Tan</surname>, <given-names>M. H.</given-names></string-name>, <string-name><surname>Lu</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Choolani</surname>, <given-names>M.</given-names></string-name>, &amp; <string-name><surname>Chan</surname>, <given-names>J. K. Y</given-names></string-name>. (<year>2013</year>). <article-title>Systemic delivery of scAAV9 in fetal macaques facilitates neuronal transduction of the central and peripheral nervous systems</article-title>. <source>Gene Therapy</source>, <volume>20</volume>(<issue>1</issue>), <fpage>69</fpage>â<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1038/gt.2011.216</pub-id></mixed-citation></ref>
<ref id="c35"><mixed-citation publication-type="journal"><string-name><surname>McGovern</surname>, <given-names>V. L.</given-names></string-name>, <string-name><surname>Iyer</surname>, <given-names>C. C.</given-names></string-name>, <string-name><surname>David Arnold</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Gombash</surname>, <given-names>S. E.</given-names></string-name>, <string-name><surname>Zaworski</surname>, <given-names>P. G.</given-names></string-name>, <string-name><surname>Blatnik</surname>, <given-names>A. J.</given-names></string-name>, <string-name><surname>Foust</surname>, <given-names>K. D.</given-names></string-name>, &amp; <string-name><surname>Burghes</surname>, <given-names>A. H. M</given-names></string-name>. (<year>2015</year>). <article-title>SMN expression is required in motor neurons to rescue electrophysiological deficits in the SMNÎ7 mouse model of SMA</article-title>. <source>Human Molecular Genetics</source>, <volume>24</volume>(<issue>19</issue>), <fpage>5524</fpage>â<lpage>5541</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddv283</pub-id></mixed-citation></ref>
<ref id="c36"><mixed-citation publication-type="journal"><string-name><surname>Mercuri</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Pera</surname>, <given-names>M. C.</given-names></string-name>, <string-name><surname>Scoto</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Finkel</surname>, <given-names>R.</given-names></string-name>, &amp; <string-name><surname>Muntoni</surname>, <given-names>F</given-names></string-name>. (<year>2020</year>). <article-title>Spinal muscular atrophy â insights and challenges in the treatment era</article-title>. <source>Nature Reviews Neurology</source>, <volume>16</volume>(<issue>12</issue>), <fpage>706</fpage>â<lpage>715</lpage>. <pub-id pub-id-type="doi">10.1038/s41582-020-00413-4</pub-id></mixed-citation></ref>
<ref id="c37"><mixed-citation publication-type="journal"><string-name><surname>Modla</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Mendonca</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Czymmek</surname>, <given-names>K. J.</given-names></string-name>, &amp; <string-name><surname>Akins</surname>, <given-names>R. E</given-names></string-name>. (<year>2010</year>). <article-title>Identification of neuromuscular junctions by correlative confocal and transmission electron microscopy</article-title>. <source>Journal of Neuroscience Methods</source>, <volume>191</volume>(<issue>2</issue>), <fpage>158</fpage>â<lpage>165</lpage>. <pub-id pub-id-type="doi">10.1016/j.jneumeth.2010.06.015</pub-id></mixed-citation></ref>
<ref id="c38"><mixed-citation publication-type="journal"><string-name><surname>Monani</surname>, <given-names>U. R.</given-names></string-name>, <string-name><surname>Pastore</surname>, <given-names>M. T.</given-names></string-name>, <string-name><surname>Gavrilina</surname>, <given-names>T. O.</given-names></string-name>, <string-name><surname>Jablonka</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Le</surname>, <given-names>T. T.</given-names></string-name>, <string-name><surname>Andreassi</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>DiCocco</surname>, <given-names>J. M.</given-names></string-name>, <string-name><surname>Lorson</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Androphy</surname>, <given-names>E. J.</given-names></string-name>, <string-name><surname>Sendtner</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Podell</surname>, <given-names>M.</given-names></string-name>, &amp; <string-name><surname>Burghes</surname>, <given-names>A. H. M</given-names></string-name>. (<year>2003</year>). <article-title>A transgene carrying an A2G missense mutation in the SMN gene modulates phenotypic severity in mice with severe (type I) spinal muscular atrophy</article-title>. <source>Journal of Cell Biology</source>, <volume>160</volume>(<issue>1</issue>), <fpage>41</fpage>â<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200208079</pub-id></mixed-citation></ref>
<ref id="c39"><mixed-citation publication-type="journal"><string-name><surname>Monani</surname>, <given-names>U. R.</given-names></string-name>, <string-name><surname>Sendtner</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Coovert</surname>, <given-names>D. D.</given-names></string-name>, <string-name><surname>Parsons</surname>, <given-names>D. W.</given-names></string-name>, <string-name><surname>Andreassi</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Le</surname>, <given-names>T. T.</given-names></string-name>, <string-name><surname>Jablonka</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Schrank</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Rossol</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Prior</surname>, <given-names>T. W.</given-names></string-name>, <string-name><surname>Morris</surname>, <given-names>G. E.</given-names></string-name>, &amp; <string-name><surname>Burghes</surname>, <given-names>A. H. M</given-names></string-name>. (<year>2000</year>). <article-title>The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophy</article-title>. <source>Human Molecular Genetics</source>, <volume>9</volume>(<issue>3</issue>), <fpage>333</fpage>â<lpage>339</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/9.3.333</pub-id></mixed-citation></ref>
<ref id="c40"><mixed-citation publication-type="journal"><string-name><surname>Nassari</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Duprez</surname>, <given-names>D.</given-names></string-name>, &amp; <string-name><surname>Fournier-Thibault</surname>, <given-names>C</given-names></string-name>. (<year>2017</year>). <article-title>Non-myogenic Contribution to Muscle Development and Homeostasis: The Role of Connective Tissues</article-title>. <source>Frontiers in Cell and Developmental Biology</source>, <volume>5</volume>(<issue>March</issue>), <fpage>1</fpage>â<lpage>17</lpage>. <pub-id pub-id-type="doi">10.3389/fcell.2017.00022</pub-id></mixed-citation></ref>
<ref id="c41"><mixed-citation publication-type="journal"><string-name><surname>Ovchinnikov</surname>, <given-names>D</given-names></string-name>. (<year>2009</year>). <article-title>Alcian blue/alizarin red staining of cartilage and bone in mouse</article-title>. <source>Cold Spring Harbor Protocols</source>, <volume>4</volume>(<issue>3</issue>), <fpage>5170</fpage>â<lpage>5172</lpage>. <pub-id pub-id-type="doi">10.1101/pdb.prot5170</pub-id></mixed-citation></ref>
<ref id="c42"><mixed-citation publication-type="journal"><string-name><surname>Passini</surname>, <given-names>M. A.</given-names></string-name>, <string-name><surname>Bu</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Roskelley</surname>, <given-names>E. M.</given-names></string-name>, <string-name><surname>Richards</surname>, <given-names>A. M.</given-names></string-name>, <string-name><surname>Sardi</surname>, <given-names>S. P.</given-names></string-name>, <string-name><surname>OâRiordan</surname>, <given-names>C. R.</given-names></string-name>, <string-name><surname>Klinger</surname>, <given-names>K. W.</given-names></string-name>, <string-name><surname>Shihabuddin</surname>, <given-names>L. S.</given-names></string-name>, &amp; <string-name><surname>Cheng</surname>, <given-names>S. H</given-names></string-name>. (<year>2010</year>). <article-title>CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy</article-title>. <source>Journal of Clinical Investigation</source>, <volume>120</volume>(<issue>4</issue>), <fpage>1253</fpage>â<lpage>1264</lpage>. <pub-id pub-id-type="doi">10.1172/JCI41615</pub-id></mixed-citation></ref>
<ref id="c43"><mixed-citation publication-type="journal"><string-name><surname>Passini</surname>, <given-names>M. A.</given-names></string-name>, <string-name><surname>Bu</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Richards</surname>, <given-names>A. M.</given-names></string-name>, <string-name><surname>Kinnecom</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Sardi</surname>, <given-names>S. P.</given-names></string-name>, <string-name><surname>Stanek</surname>, <given-names>L. M.</given-names></string-name>, <string-name><surname>Hua</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Rigo</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Matson</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Hung</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Kaye</surname>, <given-names>E. M.</given-names></string-name>, <string-name><surname>Shihabuddin</surname>, <given-names>L. S.</given-names></string-name>, <string-name><surname>Krainer</surname>, <given-names>A. R.</given-names></string-name>, <string-name><surname>Bennett</surname>, <given-names>C. F.</given-names></string-name>, &amp; <string-name><surname>Cheng</surname>, <given-names>S. H</given-names></string-name>. (<year>2011</year>). <article-title>Antisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophy</article-title>. <source>Science Translational Medicine</source>, <volume>3</volume>(<issue>72</issue>), <fpage>1</fpage>â<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1126/scitranslmed.3001777</pub-id></mixed-citation></ref>
<ref id="c44"><mixed-citation publication-type="journal"><string-name><surname>Penaud-Budloo</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Le Guiner</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Nowrouzi</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Toromanoff</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>ChÃ©rel</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Chenuaud</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Schmidt</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>von Kalle</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Rolling</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Moullier</surname>, <given-names>P.</given-names></string-name>, &amp; <string-name><surname>Snyder</surname>, <given-names>R. O.</given-names></string-name> (<year>2008</year>). <article-title>Adeno-Associated Virus Vector Genomes Persist as Episomal Chromatin in Primate Muscle</article-title>. <source>Journal of Virology</source>, <volume>82</volume>(<issue>16</issue>), <fpage>7875</fpage>â<lpage>7885</lpage>. <pub-id pub-id-type="doi">10.1128/jvi.00649-08</pub-id></mixed-citation></ref>
<ref id="c45"><mixed-citation publication-type="journal"><string-name><surname>Petrany</surname>, <given-names>M. J.</given-names></string-name>, <string-name><surname>Swoboda</surname>, <given-names>C. O.</given-names></string-name>, <string-name><surname>Sun</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Chetal</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Weirauch</surname>, <given-names>M. T.</given-names></string-name>, <string-name><surname>Salomonis</surname>, <given-names>N.</given-names></string-name>, &amp; <string-name><surname>Millay</surname>, <given-names>D. P</given-names></string-name>. (<year>2020</year>). <article-title>Single-nucleus RNA-seq identifies transcriptional heterogeneity in multinucleated skeletal myofibers</article-title>. <source>Nature Communications</source>, <volume>11</volume>(<fpage>1</fpage>). <pub-id pub-id-type="doi">10.1038/s41467-020-20063-w</pub-id></mixed-citation></ref>
<ref id="c46"><mixed-citation publication-type="journal"><string-name><surname>Ross</surname>, <given-names>J. A.</given-names></string-name>, <string-name><surname>Webster</surname>, <given-names>R. G.</given-names></string-name>, <string-name><surname>Lechertier</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Reynolds</surname>, <given-names>L. E.</given-names></string-name>, <string-name><surname>Turmaine</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Bencze</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Jamshidi</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Cetin</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Muntoni</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Beeson</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Hodilvala-Dilke</surname>, <given-names>K.</given-names></string-name>, &amp; <string-name><surname>Conti</surname>, <given-names>F. J</given-names></string-name>. (<year>2017</year>). <article-title>Multiple roles of integrin-Î±3 at the neuromuscular junction</article-title>. <source>Journal of Cell Science</source>, <volume>130</volume>(<issue>10</issue>), <fpage>1772</fpage>â<lpage>1784</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.201103</pub-id></mixed-citation></ref>
<ref id="c47"><mixed-citation publication-type="journal"><string-name><surname>Sahashi</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Ling</surname>, <given-names>K. K. Y.</given-names></string-name>, <string-name><surname>Hua</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Wilkinson</surname>, <given-names>J. E.</given-names></string-name>, <string-name><surname>Nomakuchi</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Rigo</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Hung</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Xu</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Jiang</surname>, <given-names>Y. P.</given-names></string-name>, <string-name><surname>Lin</surname>, <given-names>R. Z.</given-names></string-name>, <string-name><surname>Ko</surname>, <given-names>C. P.</given-names></string-name>, <string-name><surname>Bennett</surname>, <given-names>C. F.</given-names></string-name>, &amp; <string-name><surname>Krainer</surname>, <given-names>A. R</given-names></string-name>. (<year>2013</year>). <article-title>Pathological impact of SMN2 mis-splicing in adult SMA mice</article-title>. <source>EMBO Molecular Medicine</source>, <volume>5</volume>(<issue>10</issue>), <fpage>1586</fpage>â<lpage>1601</lpage>. <pub-id pub-id-type="doi">10.1002/emmm.201302567</pub-id></mixed-citation></ref>
<ref id="c48"><mixed-citation publication-type="journal"><string-name><surname>Scott</surname>, <given-names>R. W.</given-names></string-name>, <string-name><surname>Arostegui</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Schweitzer</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Rossi</surname>, <given-names>F. M. V.</given-names></string-name>, &amp; <string-name><surname>Underhill</surname>, <given-names>T. M</given-names></string-name>. (<year>2019</year>). <article-title>Hic1 Defines Quiescent Mesenchymal Progenitor Subpopulations with Distinct Functions and Fates in Skeletal Muscle Regeneration</article-title>. <source>Cell Stem Cell</source>, <volume>25</volume>(<issue>6</issue>), <fpage>797</fpage>â<lpage>813</lpage>.e9. <pub-id pub-id-type="doi">10.1016/j.stem.2019.11.004</pub-id></mixed-citation></ref>
<ref id="c49"><mixed-citation publication-type="journal"><string-name><surname>Shababi</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Lorson</surname>, <given-names>C. L.</given-names></string-name>, &amp; <string-name><surname>Rudnik-SchÃ¶neborn</surname>, <given-names>S. S</given-names></string-name>. (<year>2014</year>). <article-title>Spinal muscular atrophy: A motor neuron disorder or a multi-organ disease?</article-title> <source>Journal of Anatomy</source>, <volume>224</volume>(<issue>1</issue>), <fpage>15</fpage>â<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1111/joa.12083</pub-id></mixed-citation></ref>
<ref id="c50"><mixed-citation publication-type="journal"><string-name><surname>Sheng</surname>, <given-names>G</given-names></string-name>. (<year>2015</year>). <article-title>The developmental basis of mesenchymal stem/stromal cells (MSCs)</article-title>. <source>BMC Developmental Biology</source>, <volume>15</volume>(<issue>1</issue>), <fpage>26</fpage>â<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1186/s12861-015-0094-5</pub-id></mixed-citation></ref>
<ref id="c51"><mixed-citation publication-type="journal"><string-name><surname>Torres-Benito</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Neher</surname>, <given-names>M. F.</given-names></string-name>, <string-name><surname>Cano</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Ruiz</surname>, <given-names>R.</given-names></string-name>, &amp; <string-name><surname>Tabares</surname>, <given-names>L</given-names></string-name>. (<year>2011</year>). <article-title>SMN requirement for synaptic vesicle, active zone and microtubule postnatal organization in motor nerve terminals</article-title>. <source>PLoS ONE</source>, <volume>6</volume>(<fpage>10</fpage>). <pub-id pub-id-type="doi">10.1371/journal.pone.0026164</pub-id></mixed-citation></ref>
<ref id="c52"><mixed-citation publication-type="journal"><string-name><surname>Tsai</surname>, <given-names>L. K.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>C. L.</given-names></string-name>, <string-name><surname>Ting</surname>, <given-names>C. H.</given-names></string-name>, <string-name><surname>Lin-Chao</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Hwu</surname>, <given-names>W. L.</given-names></string-name>, <string-name><surname>Dodge</surname>, <given-names>J. C.</given-names></string-name>, <string-name><surname>Passini</surname>, <given-names>M. A.</given-names></string-name>, &amp; <string-name><surname>Cheng</surname>, <given-names>S. H</given-names></string-name>. (<year>2014</year>). <article-title>Systemic administration of a recombinant AAV1 vector encoding IGF-1 improves disease manifestations in SMA mice</article-title>. <source>Molecular Therapy</source>, <volume>22</volume>(<issue>8</issue>), <fpage>1450</fpage>â<lpage>1459</lpage>. <pub-id pub-id-type="doi">10.1038/mt.2014.84</pub-id></mixed-citation></ref>
<ref id="c53"><mixed-citation publication-type="journal"><string-name><surname>Uezumi</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Ikemoto-Uezumi</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Zhou</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Kurosawa</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Yoshimoto</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Nakatani</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Hitachi</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Yamaguchi</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Wakatsuki</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Araki</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Morita</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Yamada</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Toyoda</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Kanazawa</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Nakazawa</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Hino</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Fukada</surname>, <given-names>S. I.</given-names></string-name>, &amp; <string-name><surname>Tsuchida</surname>, <given-names>K</given-names></string-name>. (<year>2021</year>). <article-title>Mesenchymal Bmp3b expression maintains skeletal muscle integrity and decreases in age-related sarcopenia</article-title>. <source>Journal of Clinical Investigation</source>, <volume>131</volume>(<fpage>1</fpage>). <pub-id pub-id-type="doi">10.1172/JCI139617</pub-id></mixed-citation></ref>
<ref id="c54"><mixed-citation publication-type="journal"><string-name><surname>Vai</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Bianchi</surname>, <given-names>M. L.</given-names></string-name>, <string-name><surname>Moroni</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Mastella</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Broggi</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Morandi</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Arnoldi</surname>, <given-names>M. T.</given-names></string-name>, <string-name><surname>Bussolino</surname>, <given-names>C.</given-names></string-name>, &amp; <string-name><surname>Baranello</surname>, <given-names>G</given-names></string-name>. (<year>2015</year>). <article-title>Bone and Spinal Muscular Atrophy</article-title>. <source>Bone</source>, <volume>79</volume>, <fpage>116</fpage>â<lpage>120</lpage>. <pub-id pub-id-type="doi">10.1016/j.bone.2015.05.039</pub-id></mixed-citation></ref>
<ref id="c55"><mixed-citation publication-type="journal"><string-name><surname>Valori</surname>, <given-names>C. F.</given-names></string-name>, <string-name><surname>Ning</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Wyles</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Mead</surname>, <given-names>R. J.</given-names></string-name>, <string-name><surname>Grierson</surname>, <given-names>A. J.</given-names></string-name>, <string-name><surname>Shaw</surname>, <given-names>P. J.</given-names></string-name>, &amp; <string-name><surname>Azzouz</surname>, <given-names>M</given-names></string-name>. (<year>2010</year>). <article-title>Systemic delivery of scAAV9 expressing SMN prolongs survival in a model of spinal muscular atrophy</article-title>. <source>Science Translational Medicine</source>, <volume>2</volume>(<issue>35</issue>), <fpage>1</fpage>â<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1126/scitranslmed.3000830</pub-id></mixed-citation></ref>
<ref id="c56"><mixed-citation publication-type="journal"><string-name><surname>Van Alstyne</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Tattoli</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>DelestrÃ©e</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Recinos</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Workman</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Shihabuddin</surname>, <given-names>L. S.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Mentis</surname>, <given-names>G. Z.</given-names></string-name>, &amp; <string-name><surname>Pellizzoni</surname>, <given-names>L.</given-names></string-name> (<year>2021</year>). <article-title>Gain of toxic function by long-term AAV9-mediated SMN overexpression in the sensorimotor circuit</article-title>. <source>Nature Neuroscience</source>. <pub-id pub-id-type="doi">10.1038/s41593-021-00827-3</pub-id></mixed-citation></ref>
<ref id="c57"><mixed-citation publication-type="journal"><string-name><surname>Wasserman</surname>, <given-names>H. M.</given-names></string-name>, <string-name><surname>Hornung</surname>, <given-names>L. N.</given-names></string-name>, <string-name><surname>Stenger</surname>, <given-names>P. J.</given-names></string-name>, <string-name><surname>Rutter</surname>, <given-names>M. M.</given-names></string-name>, <string-name><surname>Wong</surname>, <given-names>B. L.</given-names></string-name>, <string-name><surname>Rybalsky</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Khoury</surname>, <given-names>J. C.</given-names></string-name>, &amp; <string-name><surname>Kalkwarf</surname>, <given-names>H. J</given-names></string-name>. (<year>2017</year>). <article-title>Low bone mineral density and fractures are highly prevalent in pediatric patients with spinal muscular atrophy regardless of disease severity</article-title>. <source>Neuromuscular Disorders</source>, <volume>27</volume>(<issue>4</issue>), <fpage>331</fpage>â<lpage>337</lpage>. <pub-id pub-id-type="doi">10.1016/j.nmd.2017.01.019</pub-id></mixed-citation></ref>
<ref id="c58"><mixed-citation publication-type="journal"><string-name><surname>Wilk</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Yeh</surname>, <given-names>S. C. A.</given-names></string-name>, <string-name><surname>Mortensen</surname>, <given-names>L. J.</given-names></string-name>, <string-name><surname>Ghaffarigarakani</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Lombardo</surname>, <given-names>C. M.</given-names></string-name>, <string-name><surname>Bassir</surname>, <given-names>S. H.</given-names></string-name>, <string-name><surname>Aldawood</surname>, <given-names>Z. A.</given-names></string-name>, <string-name><surname>Lin</surname>, <given-names>C. P.</given-names></string-name>, &amp; <string-name><surname>Intini</surname>, <given-names>G</given-names></string-name>. (<year>2017</year>). <article-title>Postnatal Calvarial Skeletal Stem Cells Expressing PRX1 Reside Exclusively in the Calvarial Sutures and Are Required for Bone Regeneration</article-title>. <source>Stem Cell Reports</source>, <volume>8</volume>(<issue>4</issue>), <fpage>933</fpage>â<lpage>946</lpage>. <pub-id pub-id-type="doi">10.1016/j.stemcr.2017.03.002</pub-id></mixed-citation></ref>
<ref id="c59"><mixed-citation publication-type="journal"><string-name><surname>Wosczyna</surname>, <given-names>M. N.</given-names></string-name>, <string-name><surname>Konishi</surname>, <given-names>C. T.</given-names></string-name>, <string-name><surname>Perez Carbajal</surname>, <given-names>E. E.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>T. T.</given-names></string-name>, <string-name><surname>Walsh</surname>, <given-names>R. A.</given-names></string-name>, <string-name><surname>Gan</surname>, <given-names>Q.</given-names></string-name>, <string-name><surname>Wagner</surname>, <given-names>M. W.</given-names></string-name>, &amp; <string-name><surname>Rando</surname>, <given-names>T. A</given-names></string-name>. (<year>2019</year>). <article-title>Mesenchymal Stromal Cells Are Required for Regeneration and Homeostatic Maintenance of Skeletal Muscle</article-title>. <source>Cell Reports</source>, <volume>27</volume>(<issue>7</issue>), <fpage>2029</fpage>â<lpage>2035</lpage>.e5. <pub-id pub-id-type="doi">10.1016/j.celrep.2019.04.074</pub-id></mixed-citation></ref>
<ref id="c60"><mixed-citation publication-type="journal"><string-name><surname>Yakar</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Rosen</surname>, <given-names>C. J.</given-names></string-name>, <string-name><surname>Beamer</surname>, <given-names>W. G.</given-names></string-name>, <string-name><surname>Ackert-Bicknell</surname>, <given-names>C. L.</given-names></string-name>, <string-name><surname>Wu</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>J. L.</given-names></string-name>, <string-name><surname>Ooi</surname>, <given-names>G. T.</given-names></string-name>, <string-name><surname>Setser</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Frystyk</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Boisclair</surname>, <given-names>Y. R.</given-names></string-name>, &amp; <string-name><surname>LeRoith</surname>, <given-names>D</given-names></string-name>. (<year>2002</year>). <article-title>Circulating levels of IGF-1 directly regulate bone growth and density</article-title>. <source>Journal of Clinical Investigation</source>, <volume>110</volume>(<issue>6</issue>), <fpage>771</fpage>â<lpage>781</lpage>. <pub-id pub-id-type="doi">10.1172/JCI0215463</pub-id></mixed-citation></ref>
<ref id="c61"><mixed-citation publication-type="journal"><string-name><surname>Yakar</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Rosen</surname>, <given-names>C. J.</given-names></string-name>, <string-name><surname>Bouxsein</surname>, <given-names>M. L.</given-names></string-name>, <string-name><surname>Sun</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Mejia</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Kawashima</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Wu</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Emerton</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Williams</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Jepsen</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Schaffler</surname>, <given-names>M. B.</given-names></string-name>, <string-name><surname>Majeska</surname>, <given-names>R. J.</given-names></string-name>, <string-name><surname>Gavrilova</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Gutierrez</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Hwang</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Pennisi</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Frystyk</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Boisclair</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Pintar</surname>, <given-names>J.</given-names></string-name>, â¦ <string-name><surname>LeRoith</surname>, <given-names>D</given-names></string-name>. (<year>2009</year>). <article-title>Serum complexes of insulin-like growth factor-1 modulate skeletal integrity and carbohydrate metabolism</article-title>. <source>The FASEB Journal</source>, <volume>23</volume>(<issue>3</issue>), <fpage>709</fpage>â<lpage>719</lpage>. <pub-id pub-id-type="doi">10.1096/fj.08-118976</pub-id></mixed-citation></ref>
<ref id="c62"><mixed-citation publication-type="journal"><string-name><surname>Yang</surname>, <given-names>Y. S.</given-names></string-name>, <string-name><surname>Xie</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Kim</surname>, <given-names>J. M.</given-names></string-name>, <string-name><surname>Tai</surname>, <given-names>P. W. L.</given-names></string-name>, <string-name><surname>Gravallese</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Gao</surname>, <given-names>G.</given-names></string-name>, &amp; <string-name><surname>Shim</surname>, <given-names>J. H</given-names></string-name>. (<year>2019</year>). <article-title>Bone-targeting AAV-mediated silencing of Schnurri-3 prevents bone loss in osteoporosis</article-title>. <source>Nature Communications</source>, <volume>10</volume>(<issue>1</issue>), <fpage>1</fpage>â<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1038/s41467-019-10809-6</pub-id></mixed-citation></ref>
<ref id="c63"><mixed-citation publication-type="journal"><string-name><surname>Yeo</surname>, <given-names>C. J. J.</given-names></string-name>, &amp; <string-name><surname>Darras</surname>, <given-names>B. T</given-names></string-name>. (<year>2020</year>). <article-title>Overturning the Paradigm of Spinal Muscular Atrophy as Just a Motor Neuron Disease</article-title>. <source>Pediatric Neurology</source>, <volume>109</volume>, <fpage>12</fpage>â<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2020.01.003</pub-id></mixed-citation></ref>
<ref id="c64"><mixed-citation publication-type="journal"><string-name><surname>Yesbek Kaymaz</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Bal</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Bora-Tatar</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Ozon</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Alikasifoglu</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Topaloglu</surname>, <given-names>H.</given-names></string-name>, &amp; <string-name><surname>Erdem-Yurter</surname>, <given-names>H.</given-names></string-name> (<year>2016</year>). <article-title>Serum IGF1 and IGFBP3 levels in SMA patients</article-title>. <source>Neuromuscular Disorders</source>, <volume>26</volume>, <fpage>S105</fpage>. <pub-id pub-id-type="doi">10.1016/j.nmd.2016.06.075</pub-id></mixed-citation></ref>
<ref id="c65"><mixed-citation publication-type="journal"><string-name><surname>Zanetti</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Negro</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Megighian</surname>, <given-names>A.</given-names></string-name>, &amp; <string-name><surname>Pirazzini</surname>, <given-names>M</given-names></string-name>. (<year>2018</year>). <article-title>Electrophysiological Recordings of Evoked End-Plate Potential on Murine Neuro-muscular Synapse Preparations</article-title>. <source>Bio-Protocol</source>, <volume>8</volume>(<issue>8</issue>), <fpage>1</fpage>â<lpage>16</lpage>. <pub-id pub-id-type="doi">10.21769/bioprotoc.2803</pub-id></mixed-citation></ref>
</ref-list>
<sec>
<fig id="figs1_1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 1 -figure supplement 1</label>
<caption><p>Growth defects in the Prrx1-lineage bone of SMN2 0-copy Smn<sup>ÎMPC</sup> mice. (<bold>A)</bold> Representative control and mutant mice with 0 copies of SMN2 were photographed at E18.5. (<bold>B-C</bold>) Alcian blue &amp; alizarine red staining in the SMN2 0-copy Smn<sup>ÎMPC</sup> mutant showed abnormal skeletal development of the limbs, (<bold>D</bold>) calvaria (shown by the dashed line), and (<bold>E</bold>) sternum (indicated by a white arrow). Scale bars, 5 mm (<bold>B-C</bold>) and 2 mm (<bold>D-E</bold>).</p></caption>
<graphic xlink:href="561282v1_figs1_1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs1_2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 1 -figure supplement 2</label>
<caption><p>Altered growth plate homeostasis independent of the IGF axis from the liver in SMN2 1-copy Smn<sup>ÎMPC</sup> mice. (<bold>A)</bold> Representative images of H&amp;E staining in the femur growth plate of control and mutant mice with 1 copy of SMN2 at P14. Scale bars, 200 Î¼m (Left) and 100 Î¼m (Right). (<bold>B-D</bold>) Hypertrophic zone (HZ) and proliferative zone (PZ), indicated by black arrows and dashed lines, lengths were reduced in SMN2 1-copy Smn<sup>ÎMPC</sup> mice, and the hypertrophic cell number in a section of the 1-copy mutant was decreased (n = 4 mice in each genotype; Unpaired t-test with Welchâs correction). (<bold>E</bold>) Relative IGF axis mRNA expression in the livers of SMN2 1-copy control and mutant mice. The IGF pathway genes showed no difference when comparing controls to SMN2 1-copy Smn<sup>ÎMPC</sup> mutants (n = 3 mice in each genotype; Unpaired t-test with Welchâs correction). ns; not significantly different. *<italic>p</italic> &lt; 0.05; **<italic>p</italic> &lt; 0.01. Error bars show s.e.m.</p></caption>
<graphic xlink:href="561282v1_figs1_2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
</back>
<sub-article id="sa0" article-type="editor-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.92731.1.sa3</article-id>
<title-group>
<article-title>eLife Assessment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ryu</surname>
<given-names>Vitaly</given-names>
</name>
<role specific-use="editor">Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>Icahn School of Medicine at Mount Sinai</institution>
</institution-wrap>
<city>New York</city>
<country>United States of America</country>
</aff>
</contrib>
</contrib-group>
<kwd-group kwd-group-type="evidence-strength">
<kwd>Convincing</kwd>
<kwd>Incomplete</kwd>
</kwd-group>
<kwd-group kwd-group-type="claim-importance">
<kwd>Important</kwd>
</kwd-group>
</front-stub>
<body>
<p>This <bold>important</bold> work by Hann et al. advances our understanding of the role of the survival motor neuron (SMN) protein in coordinating pathogenesis of the spinal muscular atrophy (SMA). The authors provide <bold>convincing</bold> but, nevertheless, <bold>incomplete</bold> evidence in terms of skeletal analyses not being able to satisfactorily elucidate SMN regulation of bone development. The paper appears to be descriptive and will benefit from additional experiments to justify the hypothesis. With amendments, this work will be of broad interest to biologists especially those working on the SMA.</p>
</body>
</sub-article>
<sub-article id="sa1" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.92731.1.sa2</article-id>
<title-group>
<article-title>Reviewer #1 (Public Review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>
The manuscript by Hann et. al examines the role of survival motor neuron protein (SMN) in lateral plate mesoderm-derived cells using the Prrx1Cre to elucidate how changing cell-specific SMN levels coordinate aspects of the spinal muscular atrophy (SMA) pathology. SMN has generally been studied in neuronal cells, and this is one of the first insights into non-neuronal cells that may contribute to SMA disease. The authors generated 3 mouse lines: a Prrx1;Smnf/f conditional null mouse, as well as, single and double copy Prrx1;Smnf/f;SMN2 mice carrying either one or two copies of a human SMN2 transgene. First, the bone development and growth of all three were assessed; the conditional null Smn mutation was lethal shortly after birth, while the SMN2 2-copy mutant did not exhibit bone growth phenotypes. Meanwhile, single-copy SMN2 mutant mice showed reduced size and shorter limbs with shorter proliferative and hypertrophic chondrocyte zones. The authors suggested that this was cell autonomous by assessing the expression of extrinsic factors known to modulate proliferation/differentiation of growth plate chondrocytes. After assessing bone phenotypes, the authors transitioned to the assessments of neuromuscular junction (NMJ) phenotypes, since there are documented neuromuscular impairments in SMA and the Prrx1Cre transgene is expressed in muscle-associated fibro-adipogenic progenitors (FAPs). Neonatal NMJ development was unchanged in mutant mice with two copies of SMN2 , but adult single-copy SMN2 mutant mice had abnormal NMJ morphology, altered presynaptic neurotransmission, and problematic nerve terminal structure. Finally, the authors sought to assess the ability to rescue NMJ phenotypes via FAP cell transplantation and showed wild-type FAPs were able to reduce pre/postsynaptic fragmentation and neurofilament varicosities.</p>
<p>Strengths:</p>
<p>
The conditional genetic approaches are novel and interestingly demonstrate the potential for chondrocyte and fibro-adipogenic progenitor-specific contributions to the SMA pathology.</p>
<p>The characterizations of the neuromuscular and NMJ phenotypes are relatively strong.</p>
<p>The data strongly suggest a non-neuronal contribution to SMA, which indicates a need for further mechanistic (cellular and molecular) studies to better understand SMA.</p>
<p>Weaknesses:</p>
<p>
The skeletal analyses are not rigorous and likely do not get to the core of how SMN regulates bone development.</p>
<p>The overall work is descriptive and lacks convincing mechanisms.</p>
<p>Additional experimentation is likely needed to fully justify the conclusions.</p>
</body>
</sub-article>
<sub-article id="sa2" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.92731.1.sa1</article-id>
<title-group>
<article-title>Reviewer #2 (Public Review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>
Sang-Hyeon et al. laid out a compelling rationale to explore the role of the SMN protein in mesenchymal cells, to determine whether SMN deficiency there could be a pathologic mechanism of SMA. They crossed Smnf7/f7 mice with Prrx1Cre mice to produce SmnÎMPC mice where exon 7 was specifically deleted and thus SMN protein was eliminated in limb mesenchymal progenitor cells (MPCs). To demonstrate gene dosage-dependence of phenotypes, SmnÎMPC mice were crossed with transgenic mice expressing human SMN2 to produce SmnÎMPC mice with different copies of SMN2 (0, 1, or 2). The paper provides genetic evidence that SMN in mesenchymal cells regulates the development of bones and neuromuscular junctions. Genetic data were convincing and revealed novel functions of SMN.</p>
<p>Strengths:</p>
<p>
Overall, the paper provided genetic evidence that SMN deficiency in mesenchymal cells caused abnormalities in bones and NMJs, revealing novel functions of SMN and leading to future experiments. As far as genetics is concerned, the data were convincing (except for the rescue experiment, see below); the conclusions are important.</p>
<p>Weaknesses:</p>
<p>
The paper seemed to be descriptive in nature and could be improved with more experiments to investigate underlying mechanisms. In addition, some data appeared to be contradicting or difficult to explain. The rescue data were not convincing.</p>
</body>
</sub-article>
<sub-article id="sa3" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.92731.1.sa0</article-id>
<title-group>
<article-title>Reviewer #3 (Public Review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>
SMN expression in non-neuronal cells, particularly in limb mesenchymal progenitors is essential for the proper growth of chondrocytes and the formation of adult NMJ junctions.</p>
<p>Strengths:</p>
<p>
The authors show copy numbers of smndelta7 in MPC influence NMJ structure.</p>
<p>Weaknesses:</p>
<p>
Functional recovery by FAP transplantation is not complete. Mesenchymal progenitors are heterogeneous, and how heterogeneity influences this study is not clear. Part of the main findings to show the importance of SMN expression in non-neuronal cells is partly published by the same group (Kim et al., JCI Insight 2022). In the study, the authors used Dpp4(+) cells. The difference between the current study and the previous study is not so clear.</p>
</body>
</sub-article>
</article>